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Background. Type 1 diabetes mellitus (T1DM) requires the ongoing self-management of 
blood glucose to minimize the likelihood of serious morbidity and premature mortality. 
Adherence to clinical recommendations is challenging and is influenced by serious short-term 
complications of self-management (e.g., hypoglycemia, hyperglycemia) and long-term 
vascular pathology (e.g., eye disease, heart attack). Worry of hypoglycemia (WoH) and worry 
of vascular complications (WVC) are two cognitive and behavioural constructs that have 
important implications for blood glucose control. Although researchers have argued that 
avoidance behaviour explains the relationship between diabetes-related worry and blood 
glucose, data supporting this assertion is lacking. Furthermore, the impact of diabetes-related 
worry and worry-driven behaviour on important health-related quality of life (HRQoL) 
dimensions is unclear. The purpose of the present study was to provide the first test of this 
avoidance behaviour mediation hypothesis, and to examine the relationships between diabetes-
related worry, avoidance behaviour and HRQoL (perceived impact; self-management 
satisfaction). M ethod. One hundred and fifty two individuals with T1DM completed a self-
report questionnaire package, and 129 participants had blood glucose values (i.e., A1C) 
available for analysis. Results. Avoidance behaviour did not mediate the relationships between 
diabetes-related worry and blood glucose. However, WoH was associated with avoidance 
behaviour, which in turn, was associated with higher blood glucose levels. Hypoglycemia 
avoidance behaviour mediated the positive relationship between WoH and the perceived 
impact of having diabetes, and WVC and hyperglycemia avoidance behaviour were 
independently associated with the perceived impact of having diabetes. While WoH and WVC 
were associated with lower satisfaction with self-management practices, hypoglycemia subtle 
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avoidance behaviour, hyperglycemia avoidance behaviour, and complication vigilance/risk 
behaviour avoidance was associated with greater satisfaction. Discussion. In the majority of 
cases, the avoidance behaviour mediation hypotheses were not supported by these data. 
However, these results highlight the differential impact of diabetes-related worry and worry-
driven behaviour on blood glucose and HRQoL among individuals with T1DM. Strengths and 
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Diabetes mellitus is a complex chronic medical condition that involves the 
dysregulation of blood glucose metabolism. As of 2005, it was estimated that 1.8 million 
Canadians have developed diabetes (Canadian Diabetes Association, 2008), and the World 
Health Organization projects that it will affect upwards of 370 million people worldwide by 
2030 (Wild, Roglic, Green, Sicree & King, 2004).  
1.1  Definitions of Diabetes 
Type 1 diabetes mellitus (T1DM) accounts for 10% of all cases of diabetes. In this 
-cells in the pancreas. These 
lin (the hormone that facilitates the 
transfer of glucose from the blood plasma into the organs and tissues of the body). This ß-cell 
destruction results in insufficient insulin production, and leads to an inability of the body to 
metabolize carbohydrates and glucose that is ingested (Lawson & Muirhead, 2001). 
Eventually, a high level of unusable glucose in the blood results in cellular death, vascular 
damage, and organ failure. The management of T1DM requires repeated insulin injections and 
lifestyle modification involving dietary choice, physical activity, self-monitoring of blood 
glucose, and medication adherence. Prior to the discovery and administration of insulin in 
humans in 1922, individuals with T1DM typically did not live beyond adolescence (Cheng & 
Zinman, 2001). All deaths resulted from a metabolic condition called diabetic ketoacidosis 
(described below). However, with the advent of insulin therapy, a long and productive life can 
be achieved, particularly when coupled with appropriate behavioural management. 
In contrast, Type 2 diabetes mellitus (T2DM) results from the cumulative effect of 
excessive energy intake coupled with insufficient energy expenditure among genetically 
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predisposed individuals. This imbalance increases the demand for insulin production by the 
pancreas to maintain a homeostatic state of blood glucose. Over time, the presence of copious 
amounts of insulin results in an irreversible cellular resistance to the insulin produced by the 
pancreas (Capes & Anand, 2001). Furthermore, chronic elevations in blood glucose are toxic, 
and destroy the pancreatic ß-cells resulting in a relative deficiency in insulin production. In 
essence, the pancreas produces less insulin; and the cells of the body are unable to effectively 
use the insulin that is produced. First line interventions include similar health behaviour change 
(i.e., dietary choice, physical activity). However, if unsuccessful at managing blood glucose, it 
is managed with medications that stimulate insulin production and/or sensitize the cells of the 
body to the insulin produced by the pancreas, and In later stages, individuals with T2DM may 
require intensive insulin therapy to maintain normal blood glucose levels.  
Regardless of the underlying pathophysiology, individuals with diabetes are faced with 
significant biopsychosocial demands that impact the management of their disease (Delamater 
et al., 2001; Fisher, Delamater, Bertelson, & Kirkley, 1982; Petrie et al., 1996; Wysocki, 
Buckoloh, Lochrie, & Antal, 2005).   
1.2 Self-Management and Disease-Related Complications 
If individuals are unable to maintain normal blood glucose levels, they risk facing a 
myriad of complications that are dispersed over time. Some complications are relatively 
episodic and frequent, where others are cumulative and eventual. For example, in the short-
term, individuals must manage the risk of acute episodes of excessively low blood glucose 
(i.e., hypoglycemia), and excessively high blood glucose (e.g., hyperglycemia; Booth, 2001; 
Yale, 2001). In the longer-term, individuals risk developing serious vascular pathology that can 
lead to blindness, renal failure, persistent neuropathic pain, myocardial infarctions (heart 
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attack), cerebral vascular accidents (stroke), or peripheral arterial disease. To gain a better 
appreciation for these short-term and long-term complications that range in severity from 
noxious yet benign, to potentially life threatening, a cursory review of these symptoms and 
states will be provided.  
1.2.1 Hypoglycemia 
Optimal blood glucose ranges from 4.0mmol/L  7.0mmoL/L (CDA, 2008). 
Hypoglycemia is defined as a state of low plasma glucose concentration (< 4.0mmol/L) that is 
accompanied by a host of aversive physical symptoms. Symptoms are divided into two 
categories and include adrenergic (i.e., trembling, heart palpitations, sweating, anxiety, hunger, 
nausea, or tingling) and transient neurological (i.e., impaired concentration, fatigue, confusion, 
weakness, drowsiness, vision changes, difficulty speaking, headache, dizziness, loss of 
consciousness, and seizures; Hepburn, 1994). In mild forms, individuals often become aware 
of these unpleasant adrenergic symptoms and are able to self-correct by administering oral 
carbohydrate (i.e., typically liquids containing glucose, such as juice or soda). In more extreme 
states, transient neurological symptoms develop and often require the assistance of others to 
correct. The results of several studies have shown that on average, mild episodes occur twice 
per week, and severe episodes occur once or twice per year (Pedersen-Bjergaard et al., 2004; 
Pramming, Thorsteinsson, Bendtson, & Binder, 1991). Furthermore, half of all instances of 
hypoglycemia occur nocturnally during sleep (Banarer & Cryer, 2003).  
Unfortunately, as a consequence to intensive insulin therapy (i.e., multiple daily 
injections) and the strict glycemic control required to minimize the risk of long-term 
complications (discussed below), the frequency of hypoglycemic episodes increases three-fold 
compared to individuals on less intensive insulin regimens (DCCT, 1997). In fact, severe 
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hypoglycemia is the most common adverse event of intensive insulin therapy (Yale, 2001). It 
has been argued to be the greatest limiting factor to the maintenance of optimal glycemic 
control because it may trigger dangerous physiological states, excessive worry, and 
maladaptive avoidance behavior (Cryer, 2002; Cryer, 1999).  
1.2.2 Hyperglycemia 
In contrast, hyperglycemia is defined as a state of elevated plasma glucose 
concentration (> 7.0mmol/L). It is accompanied by a different constellation of symptoms that 
include excessive thirst, excessive urination, fatigue, itchy skin; and over time, weight loss. In 
mild forms, individuals are often unaware of these elevations. In more flagrant episodes, 
individuals may self-detect these aforementioned symptoms. Hyperglycemia is managed by 
self-administering an injection of short-acting insulin to restore normal blood glucose levels. 
However, if untreated, extreme hyperglycemia can precipitate a state of diabetic ketoacidosis 
(DKA), which results in both the production of ketones and metabolic acidosis (Booth, 2001). 
DKA leads to excessive urination and loss of both fluid and electrolytes that can result in 
death. Repeated episodes of DKA may be evidence of poor metabolic control, which 
potentiates morbidity and premature mortality. Precipitants for DKA include infection, 
abdominal crises (e.g., gastrointestinal bleeding, pancreatitis), physical trauma (Ellermann et 
al., 1984; Wetterhall et al., 1992), and insulin omission (Levitsky et al., 1991). Prior to the 
discovery of insulin, heart attacks secondary to DKA were certain to be the cause of death in 
individuals with T1DM. 
1.2.3 Microvascular and Macrovascular Complications 
Over time, individuals with T1DM are at risk for developing a number of serious 
microvascular and macrovascular complications. Microvascular complications include 
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retinopathy (microaneurysms in the retina), nephropathy (persistently positive presence of 
albumin in the urine that represents kidney dysfunction), and neuropathy (disorders of the 
peripheral nerves). In turn, these complications each contribute to blindness, end-stage renal 
disease, sensory loss, persistent peripheral pain, and weakness. In contrast, macrovascular 
complications arise from an atherosclerotic process that leads to myocardial infarction (heart 
attack), cerebrovascular accident (stroke), and peripheral arterial disease (peripheral vascular 
damage of the arteries, veins, and lymph vessels). The predominant risk factors for the 
development of all vascular complications include chronic hyperglycemia, hyperinsulinemia 
(excess unusable insulin circulating in the blood plasma) and disruptions in lipoprotein 
metabolism (Jenkins et al., 2004). Several prospective studies have shown significant 
associations between mean blood glucose levels (i.e., > 7.0%) and the risk of vascular 
complications (UK Prospective Diabetes Study, 1998; DCCT, 1995a; Strandl et al., 1996). 
Furthermore, reductions in mean blood glucose levels results in significant reductions in the 
relative risk of both vascular complications and premature mortality. Specifically, a 1.0% 
absolute reduction in mean blood glucose levels results in a 37% reduction in the risk for 
microvascular complications, a 14% reduction in the risk for myocardial infarctions, and fewer 
all-cause deaths (Skyler, 1996; Stratton et al., 2000). A more detailed review of the prevalence 
and pathophysiology of diabetes-related vascular complications is provided elsewhere (see 
Krentz, Clough & Byrne, 2007).  
1.3 Temporal Distribution of Self-Management and Disease-Related Complications 
Individuals with T1DM are faced with the possibility of experiencing both self-
management-related complications (i.e., hypoglycemia, hyperglycemia, DKA), and disease-
related complications (i.e., microvascular and macrovascular pathology). However, the 
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incidence and potential occurrence of these consequences are distributed across time. In the 
short-term (particularly for individuals with a less advanced stage of diabetes), they face the 
regular occurrence of self-management complications as a result of blood glucose dynamics 
that are influenced by insulin administration, dietary choice, and physical activity. Early on in 
the disease process, the likelihood of occurrence of serious vascular pathology is low. 
However, for individuals with a more advanced stage of diabetes, they may be forced to 
contend with the near-future occurrence of both self-management and disease-related 
complications.  
1.4 Diabetes Self-Management Practices 
 To minimize the likelihood of experiencing these self-management and disease-related 
complications, individuals must adopt and maintain a number of adaptive health behaviours. 
These include appropriate dietary choice, regular physical activity, medication adherence, and 
frequent blood glucose self-monitoring. Furthermore, in the event of significant variations in 
blood glucose, individuals must learn how to appropriately manage acute episodes of both 
hypoglycemia and hyperglycemia to restore normal blood glucose levels.   
Over the past two decades, dietary recommendations for individuals with T1DM have 
undergone considerable revision. In 1998, the Canadian Diabetes Association (CDA) published 
the first consensus statement on the clinical practice guidelines for the detection and 
management of diabetes in Canada (Meltzer et al., 1998). At that time, dietary 
recommendations focused on meal planning. The guiding principle of meal planning involved 
consuming meals that were composed of 55% carbohydrates and 30% fats. However, this 
approach fostered rigidity in dietary choices, placed considerable limitations on food selection, 
and required individuals to eat meals at set intervals.  
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In recent years, the American Diabetes Association (ADA) and CDA have shifted away 
from meal planning and recommend that individuals learn and practice carbohydrate counting 
(a process of counting the number of grams of carbohydrates consumed) to establish an 
appropriate carbohydrate-to-insulin ratio (i.e., x grams of carbohydrate: 1 unit of insulin) 
(ADA, 2009; CDA, 2008). This ratio is unique to each individual, reflects the idiosyncrasies in 
carbohydrate and glucose metabolism, and must take into consideration anticipated energy 
expenditure. Furthermore, individuals must learn how to adjust their ratio to account for 
unexpected events that influence blood glucose metabolism (e.g., times of increased physical 
activity, high stress, or physical illness). Carbohydrate counting engenders greater flexibility in 
both dietary choices and timing of meals (DAFNE Study Group, 2002; Tunbridge et al., 1991). 
In theory, individuals are able to eat most foods by adjusting the amount of insulin 
administered to counter balance any increases in carbohydrate consumption. However, this 
method requires individuals to measure and weigh their foods to determine accurate portion 
sizes, and to determine food constituents using commercially available reference materials 
(e.g., calorie, carbohydrate, and fat counting reference books). Although there are several 
advantages associated with the increased flexibility, the demands required to accurately 
determine the constituents of foods may serve as a barrier to the consistent practice of 
carbohydrate counting.   
Regular physical activity is also a cornerstone for diabetes self-management. While 
physical activity has not been shown to improve glycemic control in individuals with T1DM 
(Laaksonen et al., 2000), it has been found to reduce the risk of morbidity and mortality by 
improving cardiorespiratory fitness (Moy et al., 1993). Currently, both the ADA and CDA 
recommend that individuals participate in 150 minutes per week of vigorous aerobic activity 
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(i.e., achieving > 70% of individuals maximum heart rate; CDA, 2008; ADA, 2009). 
ivities could include brisk walking, jogging, or 
swimming.  
Since 1922, insulin has remained an absolute indication for the treatment of individuals 
with T1DM (Cheng & Zinman, 2001). Currently, the ADA and CDA recommend the use of 
both long-acting and short-acting insulins (ADA, 2009; CDA, 2008). Long acting insulin has 
duration of action of 18-
insulin requirements between meals (Cheng et al., 2001). In contrast, short-acting insulin has 
duration of action of 4-8 hours after administration. It is administered just prior to meals and is 
intended to cover the insulin requirements for foods that are consumed. Adherence to this long-
acting and short-acting insulin regimen can effectively lower blood glucose concentrations, 
prevent or minimize hyperglycemia, and minimize the risk of both microvascular and 
macrovascular complications (DCCT, 1993). However, this regimen increases the risk of 
severe hypoglycemia (McCrimmon & Frier, 1994), and is associated with weight gain (DCCT, 
1995b).       
Self-monitoring of blood glucose is intended to provide cross-sectional data on plasma 
glucose concentration. This information is used to inform decisions about health behaviours to 
maintain or restore euglycemia (i.e., blood glucose homeostasis). The frequency of blood 
glucose self-monitoring is unique to each individual, but is typically practiced prior to meals or 
the administration of insulin, if one suspects they are at risk of significant high or low 
deviations in blood glucose, or when making behaviour choices that influence their blood 
glucose metabolism (ADA, 2009; CDA, 2008). 
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In the event that individuals believe they are experiencing high or low deviations in 
blood glucose (i.e., hypoglycemia or hyperglycemia), they are advised to check their blood 
glucose to obtain objective information (ADA, 2009; CDA, 2008). In the event of 
hypoglycemia, individuals must administer oral carbohydrate (e.g., juice, soda) to increase 
their blood glucose concentrations. In the event of hyperglycemia, individuals may administer 
an injection of short-acting insulin to reduce their blood glucose concentrations. Failure to 
obtain objective blood glucose data prior to making such behavioral adjustments could lead to 
more extreme deviations in blood glucose and place individuals in physically hazardous 
situations. For instance, administering oral carbohydrate in the absence of hypoglycemia could 
result in hyperglycemia and contribute to poor glycemic control. Likewise, administering 
insulin in the absence of hyperglycemia could result in severe hypoglycemia, seizures, or 
death.  
In light of these onerous demands to achieve and maintain euglycemia, some 
individuals with T1DM have difficulty making or sustaining the necessary health behaviours. 
Failure to maintain this homeostasis increases the risk of developing both self-management and 
disease-related complications. Achieving and maintaining euglycemia has proven to be 
daunting for most, and has been shown to be the exception rather than the rule. For example, in 
the largest multi-site prospective study of diabetes and its complications (DCCT, 1993), only 
5% of the participants attained blood glucose levels in the optimal range despite having 
received intensive insulin therapy. Therefore, despite its efficacy, the majority of individuals 
are unable to achieve and sustain the recommended level of glycemic control required to 
prevent or minimize the risk of significant morbidity and premature mortality. Consequently, 
efforts of the past two decades have been focused on understanding the biopsychosocial factors 
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that influence adherence to health behavior regimens. Identifying and addressing these factors 
will be imperative for both secondary and tertiary prevention.   
1.5 Psychological Factors in the Management of Diabetes 
Psychological factors have been argued to play a central role in how individuals adjust 
to, and subsequently adhere to diabetes self-management recommendations. In one prospective 
study, researchers reported that individuals with T1DM had a 27% probability of developing 
major depressive disorder within 10-years of being diagnosed (Kovacs et al., 1997). It has also 
been shown that depression is twice as common, and generalized anxiety disorder is three 
times more common, among patients with diabetes compared to the general population 
(Anderson et al., 2001; Grigsby et al., 2002). Furthermore, depression is associated with 
decreased adherence to both dietary recommendations and medications (Ciechanowski, Katon 
& Russo, 2000), and trait anxiety and diabetes-related psychological distress are associated 
with worse glycemic control (Niemcryk et al., 1990; Sultan et al., 2001). Therefore, individuals 
with T1DM may have a propensity for experiencing negative emotionality that may interfere 
with the consistent practice of adaptive self-management behaviours. Unfortunately, an 
inability to adhere to the complex self-management regimens increases the risk of experiencing 
significant self-management and disease-related complications. Consequently, researchers have 
begun to examine the specific role of diabetes-related worry in the self-management of T1DM.   
Individuals with T1DM are faced with the possibility of experiencing significant 
variability in their blood glucose. Depending on their history and experience with these high 
and low deviations, individuals can become focused on the possibility of experiencing future 
episodes of hypoglycemia or medical complications. In such cases, these concerns may exert 
motivational influence on diabetes self-management practices. Worry of hypoglycemia and 
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worry of vascular complications are two conceptually related constructs that relate to 
temporally dispersed self-management and disease-related events, which have shown promise 
in understanding the motivations that influence self-management practices (Cox et al., 1987; 
Cryer, 1999; Taylor et al., 2005). In this next section, the empirical literature examining these 
constructs will be reviewed.  
1.5.1 Worry of Hypoglycemia 
 Individuals with T1DM learn to recognize the symptoms of hypoglycemia (e.g., 
sweating, faintness, trembling, and tachycardia) so they can appropriately self-correct to 
restore or maintain normal blood glucose (Schachinger et al., 2005). Mild hypoglycemic 
episodes are merely unpleasant. However, more severe and prolonged periods of low blood 
glucose can precipitate transient neurological symptoms (e.g., disorientation, loss of 
consciousness, seizures, coma). Depending on the context in which they occur, individuals 
may be placed in socially, occupationally, or physically compromising or hazardous situations 
(Holmes, Hayford, Gonzalez, & Weydert, 1983; Holmes, Koepke, Thompson, Gyevs, & 
Weydert, 1984). For instance, in a recent survey of individuals with T1DM, 52% reported 
experiencing hypoglycemia while driving an automobile during the previous 12-months (Cox 
et al., 2009). Repeated exposure to severe hypoglycemia has also been shown to result in 
degrees of cognitive impairment (Hershey, Lillie, Sadler & White, 2004). In extreme cases, 
hypoglycemia can even result in death (Cryer, Davis & Shamoon, 2003). Not surprisingly, a 
history of severe hypoglycemia has been shown to activate worry about future hypoglycemic 
events (Gold, Frier, MacLeod, & Deary, 1997; Irvine, Cox, & Gonder-Frederick, 1992). 
Furthermore, worry of hypoglycemia is associated with both dispositional tendencies to be 
anxious (Polonsky, Davis, Jacobson, & Anderson, 1992), the experience of panic attacks 
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(Costea, Ionescu-Tirgovite, Chea, & Mincu, 1993), and may account for unique variance in 
important health and behavioural outcomes.  
As a consequence of worry, researchers have argued that individuals become motivated 
to avoid hypoglycemia by maintaining higher blood glucose levels (Cryer, 1999; Irvine, Cox, 
& Gonder-Frederick, 1992; Lundkvist, Berne, Bolinder, & Johsson, 2005; Surwit et al., 1982). 
Intuitively, actions taken to avoid severe hypoglycemia seem sensible, at least in the short-
term. However, over prolonged periods of time, maintaining higher blood glucose levels 
increases the risk of developing significant vascular complications. In fact, it has been shown 
that elevated mean blood glucose levels (i.e., > 7.0%) are associated with significant increases 
in the risk of developing vascular complications (DCCT, 1995a; Standl et al., 1996, UKPDS, 
1998). While concern of hypoglycemia may be justified in some circumstances (e.g., while 
driving a vehicle), persistent worry and the consistent practice of hypoglycemia avoidance 
behaviour may be a shortsighted response that poses significant long-term risks.  
The hypothesis that worry motivates avoidance behaviour is plausible. However, in a 
recent review of the worry of hypoglycemia literature (Wild et al., 2007), data appears to be 
mixed. Though this worry-avoidance phenomenon has been described in case studies (e.g., 
Cox et al., 1990) and qualitative reports (Shiu & Wong, 2000), the empirical data suggest that 
the relationships between worry, avoidance behaviour, and blood glucose are more complex 
(Irvine et al., 1992).  
The Hypoglycemia Fear Survey (HFS) was developed to measure this phenomenon 
(Cox, Irving, Gonder-Frederick, Nowacek & Butterfield, 1987). It is a 27-item measure that is 




children with T1DM (Kamps, Roberts & Varella, 2005), the HFS has remained the most 
consistently used measure among adults.  
To date, seven studies have been published examining worry of hypoglycemia in adults 
with T1DM. In addition to the original validation study (Cox et al., 1987), only one study has 
examined the relationships between the HFS and metabolic parameters (e.g., mean blood 
glucose, blood glucose variability; Irvine, Cox & Gonder-Frederick, 1992). Two additional 
studies examined the relationships between the HFS and other psychological constructs 
(Costea et al., 1993; Polonsky et al., 1992), one study was qualitative in a sample of Chinese 
speaking participants (Shiu & Wong, 2000), and two studies provided reviews of the limited 
literature and directions for future research (Gonder-Frederick et al., 2002; Wild et al., 2007). 
The remainder of the published data on worry of hypoglycemia has focused on adolescents 
with T1DM, and parents of children or adolescents with T1DM (e.g., Barnard et al., 2010; 
Haugstvedt et al., 2010).    
In one observational study of 69 patients with T1DM, researchers sought to examine 
the relationships between worry of hypoglycemia, hypoglycemia avoidance behaviour, and a 
variety of glycemic and health-related outcomes (Irvine, Cox & Gonder-Frederick, 1992). 
These researchers used a 2 x 2 design to categorize individuals into levels of risk for 
experiencing hypoglycemia. Risk level was d
glucose (high versus low) and blood glucose variability (high versus low). The results revealed 
a significant main effect for worry; such that, individuals with low-mean blood glucose 
demonstrated the highest levels of worry. They also found a mean-by-variability interaction, 
with those in the low-mean high-variability group showing the highest level of worry, 
compared to both the low-mean low-variability and the high-mean high-variability groups. 
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These authors also found no significant mean differences across the groups in the HFS 
behaviour subscale. Furthermore, neither the mean blood glucose levels, nor daily blood 
glucose readings were significantly associated with either the worry or behaviour subscales. 
This latter finding is consistent with the results of the original validation study (Cox et al., 
1987). Of note, participants of this study had relatively poor glycemic control (i.e., more prone 
to experiencing high blood glucose) and reported experiencing less than one hypoglycemic 
episode during the previous 12-month period. Consequently, their minimal experience with 
hypoglycemia likely contributed to the lack of significant associations between the worry and 
behaviour subscales, and mean blood glucose measures.  
The underlying assumption in this literature is that avoidance behaviour mediates the 
relationship between worry and mean blood glucose. This assumption has been communicated 
in several publications reviewing the clinical challenges of hypoglycemia management (e.g., 
Banarer & Cryer, 2003; Cryer 2008a; Cryer 2008b; Cryer, Davis, Shamoon, 2003). Although 
worry of hypoglycemia appears to be relevant for certain subgroups of individuals with T1DM 
(e.g., those with low mean blood glucose levels with high variability), this avoidance behaviour 
mediation hypothesis has not been directly tested.  
One possible reason for the lack of significant associations between worry of 
hypoglycemia, avoidance behaviour, and some blood glucose parameters relates to the 
structure of the behaviour subscale. Examination of items revealed that this subscale taps more 
than overt hypoglycemia avoidance. For instance, one of the items asks the frequency in which 
individuals carry fast acting sugar to be used in the event of experiencing hypoglycemia. While 
this product is intended to manage acute episodes of hypoglycemia, the act of carrying fast 
acting sugar, in and of itself, does not affect blood glucose. Rather, this sugar product would 
 
 15 
need to be ingested for it to have a direct influence on blood sugar levels. Consequently, this 
behaviour subscale appears to tap a more heterogeneous sample of behaviours than previously 
thought.  
Unfortunately, no published studies have adequately examined the component structure 
of the HFS to determine if the proposed two-component solution is indeed appropriate. In fact, 
in the original validation study (Cox et al., 1987), a factor analysis of the 27-item measure was 
conducted using a limited sample of 35 participants with T1DM. At minimum, it is 
recommended that researchers obtain a 5:1 participant to item ratio (Hatcher, 1994), with a 
10:1 ratio being more advantageous (Nunnally, 1978). Most recently, Anderbro and colleagues 
(2008) conducted a principal components analysis of an abbreviated version of this measure 
that was translated to Swedish. Researchers have not adequately assessed the factorial validity 
of the HFS using the full English version. Although theoretically, the worry of hypoglycemia 
construct may be important to assess among particular subgroups of individuals with T1DM 
(e.g., those at a higher risk of experiencing hypoglycemia), the impact of worry on a variety of 
behavioural and metabolic indices is unclear.  
1.5.2 Worry of Vascular Complications  
For some, the experience of hypoglycemia may be sufficiently averse to motivate the 
avoidance of noxious or hazardous experiences. However, there are likely other times, or for 
other individuals, in which the concern of vascular complications may be more salient. It is 
plausible that the presence of worry that is focused on a more distal set of potential outcomes 
may motivate a different constellation of self-management behaviours.  
Relative to the literature on worry of hypoglycemia, research examining the impact of 
worry of vascular complications is even more limited. Recently, Taylor and colleagues 
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developed and validated a new self-report measure to assess worry of vascular complications in 
patients with T1DM. Results of their validation study yielded a reliable and valid measure that 
assesses a unitary worry construct, and was found to account for unique variance in mean 
blood glucose levels above and beyond general negative affect and worry of hypoglycemia. 
Although worry of vascular complications is likely to have some shared variance with worry of 
hypoglycemia (i.e., these two constructs representing forms of negative affect), they reflect 
affective and behavioural reactions to potential outcomes or consequences that lie on two ends 
of a temporal continuum. All individuals with diabetes must regularly contend with acute 
episodes of hypoglycemia and hyperglycemia. However, over time and as diabetes progresses 
to more advanced stages, the potential for developing vascular complications may exert an 
increasing amount of motivational influence on current behaviour. Therefore, to appreciate 
how temporally distributed worries may motivate current self-management decisions, 
considering theories of intertemporal choice may have utility. 
1.6 Intertemporal Choice Theory in the Self-Management of T1DM 
 Recent reports by the World Health Organization (2005) indicate that the majority of 
life-threatening diseases are chronic, rather than infectious in nature. Fortunately, individuals 
are able to influence the development and management of chronic diseases by adopting a host 
of health-protective behaviours (e.g., healthy dietary choice, regular physical activity, 
avoidance of harmful substances). However, the consistent practice of health behaviours 
necessitates that individuals recognize and appreciate that their current behaviour impacts their 
later health outcomes. For example, if individuals are unaware that regular exercise minimizes 
the risk of heart disease and other ailments, the likelihood of them exercising regularly for 
primary or secondary prevention is slim. Unfortunately, many health protective behaviours are 
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often associated with many immediate costs (e.g., inconvenience, discomfort, time), despite 
their cumulative future benefits (Hall & Fong, 2007). This temporal conundrum places the self-
regulatory demand squarely between intention and behaviour, such that good intentions are not 
always translated into consistent behaviours. In support of this notion, a recent meta-analysis of 
the intention-behaviour literature found that medium to large increases in behaviour intention 
resulted in only small to medium changes in desired behaviour (Webb & Sheeran, 2006). 
Furthermore, several moderators of this association have been identified including past 
behaviour patterns, and the controllability of the behaviour. These findings suggest that health 
behaviours cannot be fully explained by intentions alone, and that the path from intention to 
behaviour is not uniform. To account for these imperfect relationships, researchers have turned 
their attention to temporal factors that influence our health choices.      
Emerging from the behavioural economic literature, intertemporal choice theory 
provides a framework to deconstruct the decision making process (for reviews, see Berns, 
Laibson & Loewenstein, 2007). Intertemporal choices involve decisions with consequences 
that emerge over time. It has been argued that such choices are influenced by three specific 
mechanisms including, 1) the anticipation of a future event or outcome, 2) self-control to resist 
immediate temptation to implement future decisions, and 3) the mental representation used to 
construe the future outcome of our choices. I will briefly define each of these mechanisms, 
before illustrating their applications with both a general and a diabetes-specific example.  
According to intertemporal choice theory, anticipation refers to the experience of 
waiting for an expected outcome. When we decide to engage in a specific behaviour, action, or 
event, there is often a lag between the time that our decision is made and the moment that we 
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execute our decision. This anticipatory period may also provoke affective responses such as 
excitement or dread.  
Self-control refers to the ability to hold out for a delayed reward in the face of a more 
attractive immediate alternative (Mischel, Shoda & Rodriguez, 1989). Related to self-control, 
preference reversals occur when individuals succumb to an immediate temptation that derails 
their ability to hold out for a delayed reward (Baumeister & Heatherton, 1996; Berns et al., 
2007).  
Finally, mental representation relates to the mental heuristics used when making a 
decision. With greater temporal distance between events, we tend to construe events in more 
abstract ways (e.g., good vs. bad). With less temporal distance, we tend to construe events in 
more concrete and tangible terms (e.g., that outcome will be bad because of X factor or factors; 
Liberman, Sagristano, & Trope, 2002; Loewenstein, Brennan, & Volpp, 2008). 
Each of the above concepts is relevant for the execution of decisions that we make. For 
instance, I have decided to attend a family reunion that is planned for this coming winter. Over 
the next few months, I experience feelings of dread in anticipation of my perpetual family 
dysfunction. However, despite this, I become acutely aware that my attendance would make 
my parents extremely happy. Although this awareness enhances my motivation and strengthens 
my decision to attend, I may experience second thoughts on my way to the reunion. Since a 
considerable amount of time has passed since my last encounter with my extended family, I 
have vague recollections that my previous experience was unpleasant. Alternatively, if I were 
unfortunate enough to have attended a family function in the recent past, I would be more 
likely to recall the details that were responsible for my negative experience (e.g., my uncle 
instigating a heated argument with my father relating to the outcome of the recent political 
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election). Consequently, my decision to attend the upcoming family reunion is influenced by 
my anticipation of the event, the extent to which I have self-control to override my drive to 
avoid the gathering, and the mental representations that I use to predict the outcome of the 
event (which are based on my previous experience).  
In the context of T1DM, individuals are faced with making decisions about a variety of 
proximal and distal outcomes that influence their overall disease management. Despite having 
a desire to be healthy with good glycemic control, the decisions that some make, may at times, 
be inconsistent with their overarching goal. For example, an individual is planning to attend an 
after work social gathering at which his/her new boss will be in attendance. After learning of 
their attendance, the individual worries that he/she might experience a hypoglycemic episode 
Despite valuing their health, this individual decides to take less insulin before attending the 
event to minimize the likelihood of experiencing hypoglycemia. After all, they recall the last 
time this happened, and their co-workers thought they were intoxicated. The following day, 
this individual was mortified when having to interact with these colleagues at work. Although 
this person values their health and overall diabetes management, they worry about 
experiencing hypoglycemia in the presence of their new boss and colleagues. This provokes a 
momentary preference reversal:  They become willing to omit part of their insulin dose to 
minimize the likelihood of being embarrassed from an episode of hypoglycemia. Their detailed 
recollection of the outcome of a similar experience strengthens their decision, despite the 
known risks associated the repeated occurrence of this behaviour.  
A variety of potential outcomes associated with diabetes may influence self-
management practices in a variety of ways. In the short-term, becoming symptomatic of 
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hypoglycemia or hyperglycemia may facilitate momentary cognitions about health that are 
more concrete, meaningful, and valued. In essence, the potential for experiencing significant 
variability in blood glucose may increase the perception of short-term threat. In contrast, the 
absence of physical symptoms associated with vascular complications may create a perception 
of increased temporal distance that results in cognitions about health that are highly abstract 
and have less motivational influence on current behaviour.  
Interim Summary 
At any given moment, individuals with T1DM make a series of decisions that influence 
their blood glucose management. In the short-term, they are faced with the self-management 
complications of hypoglycemia and hyperglycemia. In the long-term, and as diabetes advances, 
they risk the development of significant vascular complications. The experience of physical 
symptoms associated with blood glucose variability or medical complications may provide 
valuable information that influences how individuals construe and evaluate their health to 
inform their immediate decisions. When faced with such symptoms, momentary preference 
reversals may occur in response to their perception of threat. In the short-term, symptoms of 
hypoglycemia may motivate avoidance behaviour, which over time, may negatively impact 
glycemic control and increase the risk for vascular complications. In contrast, symptoms of 
vascular pathology (e.g., changes in vision, numbness or tingling in the extremities) may 
increase the salience of the threat of serious medical morbidity. Consequently, individuals may 
become increasingly motivated to avoid hyperglycemic states to improve their blood glucose 
management. Although this behavioural response is well intentioned, the outcome of 
undermanaged blood glucose may not be fully appreciated until a cascade of irreversible 
vascular damage has occurred (Begg & Schulzer, 2001; Steele, 2001).  
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Specific Aim 1. The primary aim of this dissertation is to test whether diabetes-
related avoidance behavior mediates the relationships between diabetes-related worry (worry 
of hypoglycemia, worry of vascular complications) and blood glucose.  
In the sections outlined above, the impact of diabetes-related worry and self-
management behaviours on blood glucose is considered. However, in addition to metabolic 
parameters, diabetes-related worry and self-management behaviours have the potential to 
potential impact on important quality of life dimensions, a brief review of this literature will be 
provided to frame the secondary aim of this dissertation. 
1.7 Quality of Life in T1DM 
 Quality of life (QoL) has been identified as an important variable for measurement in 
clinical investigations (Guyatt et al., 1989). It has been used to predict patient outcomes in 
clinical trials (e.g., McClellan, Anson, Birkeli & Tuttle, 1991; Ganz, Lee & Siau, 1991), and to 
evaluate the effectiveness of interventions (e.g., Gelber, Goldhirsch & Cavalli, 1991; Aulikki et 
al., 1991). Unfortunately, there is a lack of consensus on the definition of QoL (Gill & 
Feinstein, 1994), which is reflected in the various tools used in its measurement. Some 
operationalize QoL in more generic ways and use measures like the 36-item questionnaire from 
the Medical Outcomes Study (SF-36; Ware & Sherbourne, 1992), the Nottingham Health 
Profile (Hunt & McEwan, 1980), or the Sickness Impact Profile (Gilson et al., 1975). 
However, these measures tap constructs akin to health status or functional status, rather than 
the subjective 
approaches can be useful because it facilitates comparisons about health status across different 
populations and interventions (Patrick & Deyo, 1989). However, it has been argued that such 
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generic measures may not be sensitive to the nuances inherent in the experience of diabetes and 
its treatment (Hart et al., 2007).  
In contrast, others operationalize QoL in disease-specific ways (i.e., Health Related 
Quality of Life; HRQoL) using measures developed and validated to capture the nuances of 
specific disease processes and their treatment (e.g., cancer, diabetes). This increased level of 
specificity may be advantageous because it provides more clinically relevant information about 
the effects of, and interventions for, certain diseases, and may be more sensitive to illness-
specific interventions (Hart et al., 2007).  
However, attempts to compare data across studies becomes challenging because 
researchers use terms such as QoL, HRQoL, health status, and functional status 
interchangeably (Fortin et al., 2004). Furthermore, researchers are often unclear about how 
such constructs are defined, and use a variety of self-report measures to capture seemingly 
homogeneous phenomena. When comparing the differences between QoL and HRQoL, the 
former not only encompasses health-related factors but may also include non-medical aspects 
such as employment, family relationships, and spirituality (Gill & Feinstein, 1994). Although 
reconciling some of these differences in the QoL literature is beyond the scope of this current 
study, it is necessary to provide brief comment on the challenges inherent in QoL assessment 
to determine what is most informative and empirically supported for individuals with T1DM. 
Specifically, a multi-dimensional approach to evaluating quality of life has been argued to be 
important (Rubin & Peyrot, 1999). This often includes aspects of health status, and diabetes-
specific elements including the perceived impact of having diabetes, and satisfaction with self-
management practices and outcomes (Hart et al., 2007). 
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 With respect to the health status of individuals with T1DM, more intensive treatments 
have been found to delay the onset and progression of vascular complications (DCCT, 1993). 
For certain aspects of diabetes sequale (i.e., microvascular and macrovascular complications 
secondary to undermanaged managed blood glucose), health status or functional status may be 
important to assess. Using a cohort of 281 participants with T1DM, Hart and colleagues (2003) 
investigated the factors that influence health status in this population. The results of their study 
showed that the presence of hyperglycemic complaints (i.e., tiredness, weight loss, thirst, 
polyuria, polydipsia) and the presence of macrovascular complications (i.e., myocardial 
health status (i.e., both physical functioning and mental health status). Similar results have 
been reported elsewhere (e.g., Hahl, et al., 2002; Hart, Redkop, Bilo, Meyboom-de Jong, & 
Berg, 2007; Rubin & Peyrot, 1999). Not surprisingly, these data suggest that individuals may 
experience the greatest negative impact on their health status in the face of undermanaged 
diabetes, or as they become symptomatic of vascular complications.  
For other aspects of diabetes that have more proximal effects (i.e., hypoglycemia, 
hyperglycemia), health or functional status may be less relevant. However, the perceived 
impact of having diabetes and satisfaction with self-management practices and outcomes are 
two HRQoL dimensions that are more germane to the experience of self-management 
complications. The researchers of the DCCT developed and validated the Diabetes Quality of 
Life Questionnaire to assess these dimensions. It is the most widely used measure of HRQoL 
in individuals with diabetes, and provides valuable information about the experiences of living 
with this disease. The perceived impact subscale captures the extent to which individuals are 




management satisfaction subscale assesses how satisfied individuals are with a variety of self-
satisfied are you with the flexibility that you have in 
 
In examining the available literature, researchers have shown that the presence and 
severity of psychiatric symptoms (measured by self-report) and the presence or history of 
psychiatric disorders (assessed by structured clinical interview) is associated with a greater 
perceived impact of having diabetes and lower satisfaction (Jacobson, de Groot, & Samson, 
1997). Although these effects are independent of vascular complications, the mechanisms that 
account for these associations have not been delineated. However, in light of the onerous 
demands required to effectively self-manage blood glucose, the influence of self-management 
behaviours may be important to consider.  
In light of the observed relationships between psychiatric phenomenon and HRQoL 
(Jacobson et al., 1997), it is plausible that diabetes-related worry may also share similar 
associations with these HRQoL dimensions. As described above, worry of hypoglycemia may 
motivate a series of avoidance behaviours (e.g., avoiding being alone, keeping higher blood 
sugar levels). While these strategies are purposeful, they may also be associated with a greater 
perceived impact by imposing restrictions in domains that are appreciated and valued (e.g., 
independence, health maintenance). Furthermore, these behaviours may help to explain the 
relationship between worry of hypoglycemia and perceived impact. However, since 
hypoglycemia avoidance behaviors are intended to avert short-term harm, they may also be 
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associated with increased self-management satisfaction, and may help to account for the 
relationship between worry and satisfaction.  
Similarly, worry of vascular complications may motivate a different constellation of 
avoidance behaviors (e.g., avoiding eating out in restaurants, avoiding carbohydrates). 
Although these behaviours are intended to minimize the likelihood of experiencing disease-
related complications, they may impose restrictions on activities in which individuals engage 
and value (e.g., eating in restaurants; freedom in dietary choices). Therefore, these worry-
driven behaviors may help to explain the relationship between worry of vascular complications 
and perceived impact. However, in light of these self-imposed restrictions, it is likely that 
hyperglycemia avoidance behaviors are also associated with lower satisfaction, and may help 
to account of the relationship between worry and satisfaction.  
To date, no studies have been published that evaluate the impact of diabetes-related 
worry and worry-driven behaviour on HRQoL in this population. Understanding these 
relationships and the potential mediating role of diabetes-related worry behavior may help to 
identify the mechanisms that influence HRQoL in this population. 
Specific Aim 2. The second aim of this dissertation is to test whether diabetes-
related avoidance behavior mediates the relationships between diabetes-related worry and 
HRQoL (perceived impact, self-management satisfaction).  
1.8 Study Rationale 
 Researchers have shown that worry and other forms of negative emotionality are more 
common among individuals with diabetes compared to the general population. Specifically, it 
has been hypothesized that diabetes-related worry is likely to motivate a variety of behaviours 
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intended to minimize the likelihood of experiencing both the complications of self-
management and disease-related complications.  
Worry of hypoglycemia may motivate avoidance behaviours (e.g., keep my blood sugar 
higher when alone; keep my blood sugar higher when in a long meeting) that are intended to 
minimize the likelihood of experiencing hypoglycemia (e.g., Cox et al., 1987; Irvine et al., 
1992; Wild et al., 2007). In the short-term, these behavioural responses may serve a harm-
avoidance function; however, they may negatively impact blood glucose management and 
increase the risk of developing vascular complications. Furthermore, making behavioral 
adjustments (e.g., eating at the first sign of low blood sugar) in the absence of objective blood 
glucose data is ill advised. Over time, repeated and unnecessary corrections to blood glucose 
will contribute to worsening blood glucose control. Although hypoglycemia avoidance 
behaviours are the likely mechanism that explains the relationship between worry of 
hypoglycemia and blood glucose, researchers have not directly tested this assertion.  
Extending this logic, worry of vascular complications may motivate a different set of 
avoidance behaviours (e.g., avoiding eating carbohydrates or high calorie foods, avoiding 
eating out in restaurants). These behaviours are intended to avert high deviations in blood 
glucose, which over time, may minimize the likelihood of developing vascular complications. 
However, no published studies have examined the nature and extent of vascular complication 
worry behaviours in this population. Although hyperglycemia avoidance behaviors may also 
help to explain the relationship between worry of vascular complications and blood glucose, 
this will also be the first study to test this hypothesis.  
In the presence of worry, hypoglycemia avoidance behaviors are intended to manage 
the threat of experiencing hypoglycemia. These behaviors function to avert situations that are 
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perceived to be dangerous or life threatening. However, responding to perceived low 
deviations in blood glucose is likely to be associated with the perceived negative impact of 
having diabetes. In contrast, hypoglycemia avoidance behaviours may provide individuals with 
increased confidence in their ability to avoid hypoglycemia by ensuring higher mean blood 
glucose levels. Although in the short-term, worry may be associated with lower satisfaction, 
hypoglycemia avoidance behaviours may be associated with increased satisfaction, and may 
help to explain the relationship between worry of hypoglycemia and self-management 
satisfaction.    
When practiced in moderation, hyperglycemia avoidance behaviours may reflect 
adaptive self-management practices. However, these behaviours may also occur at a cost. For 
instance, avoiding eating carbohydrates, and avoiding eating out in restaurants have the 
potential to pose restrictions on domains of life that are both appreciated and valued (e.g., 
freedom in dietary choices). Therefore, when practiced to extremes or without flexibility, 
hyperglycemia avoidance behaviors may be associated with the perceived negative impact of 
having diabetes, and decreased satisfaction with diabetes self-management practices. These 
behaviours may also help to account for the relationships between worry of vascular 
complications and HRQoL dimensions. 
Considered together, diabetes self-management behaviours are imperative for the 
maintenance of blood glucose homeostasis. Depending on the context in which these 
behaviours are practiced, hypoglycemia avoidance behaviour and hyperglycemia avoidance 
behaviour may be important mechanisms that help to explain a variety of relationships between 




1.9 Study Hypotheses 
Hypothesis 1. Worry of hypoglycemia will be positively associated with both blood 
glucose level and hypoglycemia avoidance behaviour. Hypoglycemia avoidance behaviour will 
be positively associated with blood glucose level, and will mediate the relationship between 
worry of hypoglycemia and blood glucose level.  
Hypothesis 2. Worry of vascular complications will be inversely associated with blood 
glucose level, and positively associated with hyperglycemia avoidance behaviour.  
Hyperglycemia avoidance behaviour will be inversely associated with blood glucose level, and 
will mediate the relationship between the worry of vascular complications and blood glucose 
level. 
Hypothesis 3. Worry of hypoglycemia will be positively associated with both the 
perceived impact of having diabetes, and hypoglycemia avoidance behaviour. Hypoglycemia 
avoidance behaviour will be positively associated with perceived impact, and will mediate the 
relationship between worry of hypoglycemia and perceived impact.  
Hypothesis 4. Worry of vascular complications will be positively associated with both 
the perceived impact of having diabetes, and hyperglycemia avoidance behaviour. 
Hyperglycemia avoidance behaviour will be positively associated with perceived impact, and 
will mediate the relationship between worry of vascular complications and perceived impact. 
Hypothesis 5. Worry of hypoglycemia will be inversely associated with self-
management satisfaction, and positively associated with hypoglycemia avoidance behaviour. 
Hypoglycemia avoidance behaviour will be positively associated with self-management 
satisfaction, and will mediate the relationship between worry of hypoglycemia and self-
management satisfaction.  
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Hypothesis 6. Worry of vascular complications will be inversely associated with self-
management satisfaction, and positively associated with hyperglycemia avoidance behaviour. 
Hyperglycemia avoidance behaviour will be inversely associated with self-management 
























2.1 Study Design   
In this present study, a cross-sectional observational design was used. Data was 
collected from participants through surveys that were completed either online or by paper 
copy, following a regularly scheduled appointment with their endocrinologist.  
2.2 Participants  
A total of 231 individuals with T1DM were eligible to participate in this study, and 
were approached in one of three tertiary care clinics specializing in the treatment of diabetes: 
University Health Network (Toronto General Site), McMaster University Medical Centre, and 
received a diagnosis of T1DM, were receiving intensive exogenous insulin therapy, and were > 
18-years-old. A total of 215 individuals (93%) provided informed consent to participate, and 
152 (71%) completed a self-report questionnaire. Of those participants who completed the 
questionnaire package, 129 (84%) had recent A1C values available in their electronic medical 
records. Participants who represented a wide range of age, duration of illness, and presence of 
diabetes-related medical complications were sought to ensure adequate amounts of variance in 
these variables.  
2.3 Measures 
 2.3.1 Demographic Information.  Participants were asked to respond to a series of 
demographic questions that assessed information relating to sex, age, employment status, 
current relationship status, and education (see Table 1 of the Appendix). Information on 
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participant income was obtained by linking the first three digits of their postal code to a 
geographical information systems (GIS) database based on 2006 Canadian census data.  
2.3.2 Health Information. Participant health information was obtained by review of 
electronic medical records. In cases where community-based physicians were treating 
participants for their diabetes, informed consent was obtained to collect this information. The 
following information was sought: 1) recent A1C as an index of glycemia (see below for a 
detailed description), 2) duration since diagnosis with T1DM, 3) nature of current insulin 
therapy, 4) presence of microvascular complications (e.g., retinopathy, neuropathy, 
nephropathy), 5) presence of macrovascular complications (e.g., coronary artery disease, 
cerebrovascular disease, peripheral arterial disease).  
To ensure the completeness of these data, particularly in cases where health record data 
were missing, participants were asked to self-report on the presence of both microvascular and 
received laser eye treatment for retinopathy?; Do you have kidney disease as a result of your 
diabetes?; Are you currently receiving hemodialysis treatment?; Do you have nerve disease as 
a result of your diabetes [i.e., pain or numbness in hands or feet]?; Have you experienced any 
ulcers on your hands or feet?; Have you received any amputations because of advanced nerve 
disease related to your diabetes?). Participants were also asked to report the number of severe 
hypoglycemic episodes that they have experienced in the past 12-months. Severe episodes of 
hypoglycemia were defined as a state of low blood sugar that required the assistance of others 
-months, how many times has your blood sugar been so 
researchers to examine the frequency of severe hypoglycemia because objective measures of 
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this phenomenon have been lacking (e.g., Cox et al., 2009; Gonder-Frederick et al., 2006; 
Nordfeldt, & Jonsson, 2001). In the event of discrepancies between participant self-report and 
electronic medical record data, the information contained in the electronic medical records 
were be considered to be the more accurate of the two.  
2.3.3 Glycemic Control (A1C). 
of achieved glycemic control. It provides an index of the mean blood glucose levels over the 
previous 90-120 days. A1C is assessed through a blood sample that is analyzed in the 
laboratory. Over the 120-day life span of red blood cells, glucose molecules bind to 
hemoglobin to form glycated hemoglobin. A concentration of glycated hemoglobin in the red 
blood cells reflects the average level of glucose that the red blood cells have been exposed to 
during its lifespan; this glycated hemoglobin is then expressed as a percentage. For individuals 
with T1DM, it is recommended that A1C be assessed every 3 months (CDA, 2008). These data 
are then used to inform clinical decision-making regarding medication and lifestyle 
management. Higher A1C is indicative of worse glycemic control. Optimal A1C is considered 
to be < 6%. Failure to maintain A1C < 6% has been shown to increase the risk of developing 
microvascular and macrovascular pathology, and premature mortality (DCCT, 1993, 1997). 
For individuals with elevated A1C (> 6%), a 1.0% absolute reduction results in a 37% 
reduction in the risk for microvascular complications, a 14% reduction in the risk for 
myocardial infarctions, and fewer all-cause deaths (Stratton et al., 2000). Therefore, routine 
and ongoing assessment of A1C is imperative to inform medical and self-management 
decision-making to promote optimal diabetes management.  
2.3.4 Hypoglycemia F ear Survey (H FS; Cox et al., 1987). The HFS was developed to 
assess the presence of worry associated with the experience of hypoglycemia symptoms. This 
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measure consists of 27-items that span two domains that include worry related to the 
r is likely 
-point Likert scale that 
ranges from 1 (never) to 5 (very often). Results of a validation study found the internal 
 
Consistent with the original validation study (see Cox et al., 1987), the reliability of the 
HFS worry subscale in this present study was found 
revealed that the behaviour subscale taps a heterogeneous sample of behaviours that 
individuals might engage in response to worry. Consequently, a principle components analysis 
(PCA) was performed on these behaviour items to determine the unique component structure in 
this sample. The results of this analysis are presented below.  
2.3.5 F ear of Complications Questionnaire (F OCQ; Taylor, Crawford, & Gold, 
2005). The FOCQ was developed to assess the presence of worry related to the development of 
vascular complications associated with T1DM. This scale consists of 15-items that load on a 
unitary factor that accounts for 56% of the total variance. Participants are asked to respond to 
questions using a four-point Likert scale that ranges from 1 (very or all the time) to 4 (not at all 
or never). Results from the initial validation study found the FOCQ to be internally consistent 
(Cron
demonstrating its distinction from the HFS (described above). To evaluate the behaviours that 
individuals are motivated to engage in response to worry of vascular complications, a 
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behaviour subscale was constructed for use in this present study. Items were generated in 
consultation with diabetes healthcare professionals, and individuals with T1DM. Specifically, 
individuals were asked to provide a list of behaviors that individuals might engage in response 
to concerns about developing vascular complications. A total of 13 behaviour items were 
generated.  
Consistent with the original validation study, the internal consistency reliability of the 
FOCQ worry subscale was found to be stron
subscale was generated for use in this current study, a PCA was performed to examine its 
component structure. The results of this analysis are also presented below.  
2.3.6 Diabetes Quality of Life (DQOL; Diabetes Control and Complications Trial, 
1988). The DQOL was developed by investigators of the DCCT to assess the HRQoL of 
individuals with T1DM. Participants are asked to respond to 46-items that span five domains 
that include: 1) the perceived impact of having diabetes, 2) self-management satisfaction, 3) 
worry (social/vocational), 4) worry (illness-related), and 5) overall quality of life. However, to 
avoid criterion contamination, participants only completed the perceived impact and self-
management satisfaction subscales. Participants are asked to respond to questions using a five-
point Likert scale that ranges from 1 (very satisfied/no impact) to 5 (very dissatisfied/always 
impacted). The results of studies examining the psychometric properties of the DQOL have 
found good inte -.92), and excellent test-retest 
reliability with a mean inter-trial interval of nine days (rs = .78-.92). Further tests of construct 
validity were conducted using conceptually related measures of diabetes-related distress, and 
were found to be in the moderate range (rs ranging from .34-.60).  
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The internal consistency reliability of the perceived impact and self-management 
similar 
to those reported elsewhere (DCCT, 1988; Jacobson, de Groot, & Samson, 1994). 
2.4 Procedure 
 Participants were recruited from three tertiary care clinics specializing in the treatment 
of diabetes including: University Health Network (Toronto General Site), McMaster University 
approached in the clinic waiting rooms during their scheduled appointments with their 
endocrinologist. Study details were also advertised in designated areas around these three 
hospitals, and recruitment advertisements were placed in local diabetes newsletters. Interested 
parties who were not approached in clinic contacted the researchers by telephone or email to 
solicit further information about the study. Individuals were then mailed an information letter 
outlining the details of the study, and were asked to return their completed consent form to 
researchers by mail. Once informed consent was obtained, all participants were asked to 
complete a self-report questionnaire package either electronically (using their home computer) 
or by paper copy. If by paper copy, they were asked to return their completed questionnaire to 
researchers by mail using a self-addressed stamped envelope that was provided. Participants 
who failed to submit their completed surveys within 14-days were sent reminders by telephone 
or email.  
Participants also provided written and informed consent for the researchers to collect 
specified health information from their electronic medical records (outlined above). This study 




2.5 Data Analytic Plan 
Prior to conducting the primary analyses (described below), the distribution of each 
variable was examined using Shapiro- -Q plots. 
Non-normally distributed variables were mathematically transformed.  
Principal components analysis (PCA) was used to examine the component structure of 
the HFS and FOCQ. PCA is used to identify linear components that exist within a data set, and 
to understand how particular items contribute to a given component (Field, 2000). It uses 
correlations among the variables to identify smaller sets of components that empirically 
summarize the data (Tabachnick & Fidell, 2007). PCA was selected over Exploratory Factor 
Analysis (EFA) because the latter is better suited for hypothesis generation, rather than 
describing patterns that exist among observed variables. Although EFA also results in clusters 
of variables (i.e., factors) that highly correlate with each other, it is used to develop theories 
about underlying processes (e.g., personality tr
items that result in such factors (Tabachnick et al., 2007). The question of interest in this 
present study is how items on the diabetes-related worry scales relate to each other to form 
interpretable patterns. For this reason, PCA was selected for use in these analyses.   
One major methodological consideration when performing a PCA involves determining 
the number of independent observations (i.e., sample size) required to obtain a component 
pattern that approximates the population pattern (Guadagnoli & Velicer, 1988). Based on the 
shrinkage concept in multiple regression, correlation coefficients become adequate estimators 
of the population correlation coefficient when sample sizes reach a minimum threshold. In the 
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case of PCA, some researchers argue for the use of absolute minimum sample sizes, whereas 
other researchers argue that participant to item ratios are more important. For instance, some 
support absolute minimum sample sizes as small as an N of 50 (Barrett & Kline, 1981) and as 
large as 400 (Aleamoni, 1976). However, in the case of participant to item ratios, some suggest 
a minimum of 5:1 (Gorsach, 1983; Hatcher, 1994), whereas others argue that a minimum of 
10:1 is necessary (Nunnally, 1978, p.421). Based on a series of Monte Carlo simulation 
studies, larger ratios become underscored when items are found to have low to moderate 
component saturations (i.e., component loadings in the range of .40-.60; Guadagnoli et al., 
1988). Conducting a PCA with an inadequate sample size results in random and non-replicable 
components (e.g., Aleamoni, 1976), unstable component structures (Cliff, 1970), and a lack of 
generalizability to the population of interest (MacCallum et al., 1999).   
The HFS and FOCQ (described above) are the two measures that were subjected to 
PCA. Each scale contains 27-items, and 28-items, respectively. Depending on the 
recommendations employed, the minimum sample size required to produce stable component 
patterns may be 140 (assuming that strong component saturations are produced), with 280 
being more advantageous. Since differentiating between types of diabetes-related worry 
behavior was of utmost concern, the PCAs were limited to the HFS and FOCQ behavior 
subscales. Although this assumes that diabetes-related worry is homogeneous (i.e., that worry 
items likely load onto a single component), this has typically been the case in prior studies 
conducted by proponents in this field (e.g., Cox et al., 1987; Irvine et al. 1992; Polonsky et al., 
1992; Taylor et al., 2005). By limiting the PCA to these two behavior dimensions results in the 
inclusion of 10-items for the HFS and 13-items for the FOCQ. This conservative approach 
results in participant to item ratios of approximately 14:1 and 11:1 for the HFS and FOCQ 
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behaviour subscales, respectively. Consequently, this will maximize the ability to approximate 
the different types of diabetes-related worry behaviors practiced in the population, and will 
help to ensure stable and replicable component solutions. 
test was used to determine the number of components in each analysis that was most 
appropriate to retain. The extracted components were then subjected to orthogonal rotation. 
The purpose of rotation is to facilitate the identification a component solution that is equal to 
the solution obtained during extraction, while providing the most parsimonious interpretation 
(DeCoster, 1998). Specifically, Varimax rotation was selected because it maximizes the 
dispersion of loadings within a given component (e.g., making high loadings following 
extraction higher after rotation) resulting in more interpretable component solutions. 
To test the main hypotheses in this study, mediation analyses were performed using 
hierarchical multiple regression as outlined by Baron and Kenny (1986). According to this 
method, a mediating variable accounts for the relation, in whole or in part, between a predictor 
variable and a criterion. Statistical mediation is presumed if the following conditons are met:  
1) variable A (predictor variable) is significantly associated with variable B (the hypothesized 
mediating variable); 2) variable B (the hypothesized mediator) is significantly associated with 
variable C (the criterion variable); 3) when these paths are controlled, a previously significant 
association between variable A (predictor variable) and variable C (the criterion variable) is 
attenuated or becomes non-significant. Subsequently, the presence of mediation can be tested 
statistically by using the Sobel Test or the bootstrap method (for reviews, see Preacher & 
Hayes, 2008). In this present study, the Sobel Test was used because it has been argued to 





3.1 Demographics. A total of 231 individuals were invited to participate in this study. Of 
these individuals, 215 (93%) provided informed consent, and 152 (71%) completed and 
returned the study survey. Reasons for individuals declining participation included a lack of 
interest in participating in research studies, and a perceived lack of time to complete the study 
survey. Of those who agreed to participate, reasons for not returning the completed survey 
included participants having lost their login information for the online survey, having lost the 
paper copy of the survey, having forgotten to complete and/or return the survey, and a 
perceived lack of time to complete the survey.  
Of the participants who completed the self-report questionnaires, 129 (84%) had an 
A1C values available in their medical record. There was a mean difference of 62.3 days (SD = 
-report questionnaires and their 
most recent A1C assessment. The mean age of study completers was 39.4 years (SD = 13.7), 
whereas the mean age of the non-completers was 34.0 years (SD = 13.3). This mean difference 
was statistically significant (t151 = -2.45, p < .02), indicating that the study completers were 
older than the study non-completers. Sixty-four percent of study completers were female, and 
the majority were Caucasian (90%), married (46.8%), had completed college/university 
(44.2%), and were employed Full-time (50.6%). Based on 2006 Canadian Census data, the 
mean household income of participants was $45,353 (SD = $22,845). The mean difference in 
household income between study completers and non-completers was not statistically 
significant (t151 = 1.86, p < .07). Demographic characteristics are presented in Table 1. 
Insert Table 1 about here. 
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3.2 Background Health Information. When available, A1C values were collected from the 
electronic medical records of all participats in this study. Alternatively, requests for A1C data 
were sent to any community-based physicians treating study participants for their diabetes. A 
total of 171 participants had A1C values available for collection. The mean A1C of study 
completers was 7.60 (SD = 1.13), and the mean A1C of non-completers was 7.72 (SD = 1.14). 
This difference was not statistically significant (t175 = .56, p = .58). The mean number of severe 
hypoglycemic episodes experienced during the previous 12-months was 1.43 (SD = 1.41). The 
mean number of vascular complications that participants had developed was .35 (SD = .67). 
Diabetes-related medical characteristics of the participants are presented in Table 2.  
Insert Table 2 about here. 
 
3.3 Distribution of Variables.  
 Shapiro- -Q 
plots were also examined. The results Shapiro-  
Insert Table 3 about here. 
 
The results of this analysis showed that all variables were non-normally distributed. The only 
exception was the DQOL satisfaction subscale. Skewed variables were subjected to one of two 
transformations. Since the self-reported number of hypoglycemic episodes and self-reported 
number of vascular complications variables each contained values of zero, these variables were 
subjected to square root transformations. The remianing non-normally distributed variables 
were logarithmically transformed. Following transformation, Shaprio- -Q 
plots were re-examined. Analysis of these data showed that the variables used in the primary 
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analyses were corrected to normal or near-normal distributions. A1C, worry of hypoglycemia, 
and worry of vascular complications were normalized (Shapiro-Wilk = .98-.99, p = .05-.21). 
The distributions for hypoglycemia avoidance, hyperglycemia avoidance, and perceived impact 
were substantially improved (Shapiro-Wilk = .97-.98, p = .01-.03). The presence and history of 
self-management and disease-related complications was marginally improved (Shapiro-Wilk = 
.51-.85, p = .001). To ensure that the assumption of normally-distributed residuals was not 
violated in any of the regression models (described below), scatter-plots of the standardized 
predicted and observed values were examined. Standardized scores for the satisfaction subscale 
were used in subsequent analyses.   
 Outliers were identified usi
examined to ensure the accuracy of data entry. Valid and extreme values were then Winsorized 
to the upper and lower quartiles. Given the relatively small sample size, this procedure was 
selected to preserve the maximum power in the analyses (Wilcox 1994). The following number 
of values were trimmed for each of the following variables:  A1C (two extreme high values), 
HFS-Worry (eight extreme high values), HFS-Behaviour (one extreme high value), presence of 
vascular complications (seven extreme high values), and 12-month frequency of severe 
hypoglycemia (seven extreme high values).    
3.4 Principal Components Analysis. As previously discussed, the behaviour subscale items 
for both the HFS and FOCQ tap a heterogeneous sample of worry behaviours. Since no 
published studies have adequatley evaluated the full English version of the HFS, and the 
FOCQ behaviour subscale represents a new dimension, PCA was used to examine their 
compoent structures.  
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3.4.1 H FS-Behaviour. 
indicated that a 3-factor solution accounting for 55% of the total variance may be appropriate 
because three factors had eigenvalues greater than one (2.61, 1.67, 1.23). A 4-factor solution 
was also considered, which accounted for 64% of the total variance. However, two items cross-
loaded onto more than one factor, and two factors were composed of only two items. Since this 
resulted in a less parsimonious solution, the 3-factor solution was retained. The scree plot for 
the HFS-behaviour subscale is presented in figure 1. 
Insert figure 1 about here 
 
Individually, the amount of variance (after rotation) accounted for by factors 1-3 were, 26.1%, 
16.7%, and 12.3%, respectively. No items cross-loaded onto more than one factor, and there 
were no hyperplane items (i.e., items that failed to saliently load on at least one factor).  
The factor loadings and communalities (h2) for the HFS Behaviour 3-factor solution are 
presented in Table 4.  
Insert table 4 about here 
 
Examination of the item content revealed three clusters of items that could be interpreted as 
hypoglycemia avoidance behaviours (Factor 1), hypoglycemia compensatory behaviours 
(Factor 2), and hypoglycemia subtle avoidance behaviours (Factor 3). These components are 
operationalized as follows:  Hypoglycemia avoidance behaviors are proactive actions taken to 
ry behaviors are reactive actions taken to 
minimize the likelihood of experiencing hypoglycemia when the risk appears to be imminent 
 
 43 
mia subtle avoidance behaviors are proactive actions taken to 
-  
3.4.2 F OCQ-Behaviour. F
scree test indicated that a 3-factor solution may also be appropriate because three factors had 
eigenvalues greater than one (2.82, 1.61, 1.22). This solution accounted for 43% of the total 
variance. Similarly, a 4-factor solution was also considered, which accounted for 53% of the 
total variance. However, two items cross-loaded onto more than one factor, and two factors 
were composed of only two items. Since this resulted in a less parsimonious solution, the 3-
factor solution was retained. The scree plot for the FOCQ-behaviour dimension is presented in 
figure 2.  
Insert figure 2 about here 
 
Individually, the amount of variance (after rotation) accounted for by factors 1-3 were, 21.7%, 
12.4%, and 9.36%, respectively. Once again, no items cross-loaded onto more than one factor, 
and there were no hyperplane items. The factor loadings and communalities (h2) for the FOCQ 
Behaviour 3-factor solution are shown in Table 5.  
Insert table 5 about here 
 
Examination of the item content suggested three conceptual clusterings that represent 
complication vigilance/risk behavior avoidance (Factor 1), hyperglycmeia avoidance 
behavours with diet and exercise (Factor 2), and hyperglycemia compensatory/reassurance 
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behaviours (Factor 3). These components are operationalized as follows:  Complication 
vigilance/risk behavior avoidance are proactive actions taken to either detect signs and syptoms 
r avoid identified 
health risk behavior (i.e., alcohol consumption); hyperglycemia avoidance behaviour with diet 
and exercise are proactive actions taken relating to dietary choice and exercise that are 
intended to avoid hyperglycemia; hyperglycemia compensatory/reassurance behaviors are 
reactive actions taken either in response to hyperglycemia or that provide reassurance around 
diabetes self-management practices.  
3.5 Relationships Between Diabetes-Related Worry and Worry Behaviours 
To examine the bivariate relationships between diabetes-related worry and worry-
driven behaviours, a series of Pearson correlations were calculated. These correlations are 
presented in Table 6. 
Insert table 6 about here. 
 
The results of these analyses showed that worry of hypoglycemia was significantly related to 
hypoglycemia avoidance behaviour (r = .34, p < .001), and hypoglycemia compensatory 
behaviour (r = .21, p < .01). However, worry of hypoglycemia was not significantly related to 
hypoglycemia subtle avoidance behaviours (r = .12, p < .15). In contrast, worry of vascular 
complications was significantly related to complication vigilance/risk behaviour avoidance (r = 
.30, p < .001). However, it was not significantly related to hyperglycemia avoidance behaviour 
with diet and exercise (r = .09, p < .30) or hyperglycemia compensatory/reassurance behaviour 




3.6 Diabetes-Related Worry, Avoidance Behaviour, and Glycemic Control 
To test the first and second hypotheses that avoidance behaviour mediates the 
relationships between diabetes-related worry and glycemic control, a series of hierarchical 
multiple regressions were conducted. On the first step of each model, demographic variables 
(sex, age, income) that have previously been shown to account for significant proportions of 
variance in glycemic control were entered as control variables. Although including the duration 
since diagnosis with T1DM as a control variable was desired, this information was only 
available for 116 (76%) of participants. Therefore, this variable was excluded from the 
analyses to preserve statistical power. In the first models (model 1), the independent variables 
of interest (i.e., worry of hypoglycemia, worry of vascular complications) were each entered as 
predictors in separate models, and A1C was entered as the criterion. In the second models 
(model 2), the same independent variables (i.e., worry of hypoglycemia, worry of vascular 
complications) were each entered as predictors, and the hypothesized mediating variables (i.e., 
hypoglycemia avoidance behaviour, hyperglycemia avoidance behaviour) were entered as the 
criterion. In the third models (model 3), both the hypothesized mediating variables and 
independent variables were entered simultaneously on the second step, and A1C was entered as 
the criterion.  
A schematic of the first hypothesis is presented in Figure 3.  
Insert Figure 3 about here 
 
The results from the first set of analyses showed that worry of hypoglycemia was not a 
significant predictor of A1C (ß = -.12, p < .19). However, hypoglycemia avoidance behaviour 
was positively associated with A1C (ß = .22, p < .05); such that, greater avoidance behaviour 
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was associated with worse glycemic control. Furthermore, worry of hypoglycemia was 
positively associated with hypoglycemia avoidance behaviour (ß = .37, p < .001). Since the 
independent effect of worry of hypoglycemia on A1C was not statistically significant, there is 
no evidence of mediation. However, hypoglycemia avoidance behaviour is acting as a 
suppressor variable. This suggests that hypoglycemia avoidance behavior suppressed irrelevant 
variance in A1C. In turn, this enhanced the magnatude of the relationship between worry and 
A1C when avoidance behaviour was included in the model. Of note, age was inversely 
associated with hypoglycemia avoidance behaviour (ß = -.16, p < .05), suggesting that 
avoidance behaviours are associated with younger age. While the association between age and 
avoidance behavior is statistically significant, it may not be clinically meaningful since this 
relationship could be confounded by other factors (e.g., health status). A summary of this 
mediation model is presented in Table 7.  
Insert Table 7 about here 
 
A schematic of the second hypothesis is presented in Figure 4.  
Insert Figure 4 about here 
 
The results of these analyses showed that worry of vascular complications was not a significant 
predictor of either A1C (ß = .14, p < .11) or hyperglycemia avoidance behaviour (ß = .07, p < 
.43). Furthermore, hyperglycemia avoidance behaviour was not a significant predictor of A1C 
(ß = -.16, p < .09). Consequently, there is no evidence of statistical mediation. A summary of 
this mediation model is presenced in Table 8.   
Insert Table 8 about here 
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3.7 Diabetes-Related Worry, Avoidance Behaviour, and Perceived Impact 
To test the third and fourth hypotheses that avoidance behaviour mediates the 
relationships between diabetes-related worry and the perceived impact of having diabetes, a 
further series of hierarchical multiple regressions were performed. On the first step of each 
model, demographic variables (sex, age, income) were entered as control variables. According 
to the recommendations outlined by Rubin and Peyrot (1999), it is important to destinguish 
between objective health factors and subjective perceptions when evaluating HRQoL. Since 
health factors are likely to explain significant proportions of unique variance in HRQoL, the 
experience of severe hypoglycemic episodes during the previous 12-months, and the number of 
vascular complications that participants had developed were added as additional control 
variables on the second step of the models that use HRQoL constructs (i.e., perceived impact, 
self-management satisfaction) as the criterion. This will permit the determination of the unique 
influences of diabetes-related worry and avoidance behavior on these HRQoL dimensions.  
In the first models (model 1), the independent variables of interest (i.e., worry of 
hypoglycemia, worry of vascular complications) were each entered as predictors in separate 
models, and perceived impact was entered as the criterion. In the second models (model 2), the 
same independent variables (i.e., worry of hypoglycemia, worry of vascular complications) 
were entered as predictors, and the hypothesized mediating variables (i.e., hypoglycemia 
avoidance behaviour, hyperglycemia avoidance behaviour) were entered as the criterion. In the 
third models (model 3), both the hypothesized mediating variables and independent variables 
were entered simultaneously, and perceived impact was entered as the criterion.  
A schematic of the third hypothesis is presented in Figure 5.  
Insert Figure 5 about here 
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The results of these analyses showed that worry of hypoglycemia was a significant predictor of 
perceived impact (ß = .52, p < .001); such that greater worry was associated with a greater 
perceived impact of having diabetes. Furthermore, worry of hypoglycemia was positively 
associated with hypoglycemia avoidance behaviour (ß = .37, p < .001). In turn, hypoglycemia 
avoidance behaviour was positively associated with perceived impact (ß = .21, p < .01). The 
association between worry of hypoglycemia and perceived impact was partially accounted for 
by hypoglycemia avoidance behaviour, providing support for the mediation hypothesis (Sobel 
= 2.36, p < .02). A summary of this mediation model is presenced in Table 9.  
Insert Table 9 about here 
 
A schematic of the fourth hypothesis is presented in Figure 6.  
Insert Figure 6 about here 
 
The results of these analyses showed that worry of vascular complications was a significnat 
predictor of perceived impact (ß = .46, p < .001); such that, greater worry was again associated 
with greater perceived impact. Although hyperglycemia avoidance behaviour was positively 
associated with perceived impact (ß = .18, p < .02), the independent association between worry 
of vascular complications and hyperglycemia avoidance behaviour was not significant. 
Consequently, there is no evidence of mediation. It appears that age was the only significant 
predictor of hyperglycemia avoidance behaviour (ß = .29, p < .001); with avoidance behaviours 
being associated with being older. A summary of this mediation model is presenced in Table 
10.  
Insert Table 10 about here 
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3.8 Diabetes-Related Worry, Avoidance Behaviour, and Self-Management Satisfaction 
To test the fifth and sixth hypotheses that avoidance behaviour mediates the 
relationships between diabetes-related worry and self-management satisfaction, a similar series 
of hierarchical multiple regressions were performed (as outlined above). A schematic of the 
fifth hypothesis is presented in Figure 7.  
Insert Figure 7 about here 
 
The results of these analyses showed that worry of hypoglycemia was a significant 
predictor of self-management satisfaction (ß = -.17, p < .05); such that, greater worry was 
associated with less satisfaction. Furthermore, worry of hypoglycemia was positively 
associated with hypoglycemia avoidance behaviour (ß = .37, p < .001). However, since the 
independent association between hypoglycemia avoidance behaviour and self-management 
satisfaction was not significant (ß = -.11, p < . 24), there is no evidence of mediation. A 
summary of this mediation model is presenced in Table 11.  
Insert Table 11 about here 
 
A schematic of the sixth hypothesis is presented in Figure 8.  
Insert Figure 8 about here 
 
The results of these analyses showed that worry of vascular complications was a significant 
predictor of self-management satisfaction (ß = -.42, p < .001); such that, greater worry was 
similarly associated with less satisfaction. Although hyperglycemia avoidance behaviour was 
positively associated with self-management satisfaction (ß = .16, p < .04), the independent 
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association between worry of vascular complications and hyperglycemia avoidance behaviour 
was not significant (ß = .07, p < .43). Consequently, there is no evidence of mediation. A 
summary of this mediation model is presenced in Table 12.  
Insert Table 12 about here 
 
3.9 Exploratory Analyses 
In the primary analyses described above, the relationships between diabetes-related 
worry (i.e., worry of hypoglycemia, worry of vascular complications), avoidance behaviour, 
and glycemic control, and HRQoL, were considered. However, the consequence of severe 
hypoglycemia on the experience of worry of hypoglycemia and hypoglycemia avoidance 
behaviour in this sample is unclear. Furthermore, the impact of vascular complications on the 
experience of both worry of vascular complications and hyperglycemia avoidance behaviour is 
not known. In this next section, these questions were considered. It was anticipated that the 
recent experience of both episodes of severe hypoglycemia and vascular complications, will be 
positively associated with both avoidance behaviour and diabetes-realted worry. In turn, worry 
will be positively associated with avoidance behaviour. It is also anticipated that diabetes-
related worry will mediate the relationships between self-management and disease-related 
complications (i.e., episodes of severe hypoglycemia, number of vascular complications) and 
avoidance behaviours.  
3.9.1 Self-Management and Disease-Related Complications, Diabetes-Related Worry, 
and Avoidance Behaviour 
To examine whether diabetes-related worry (i.e., worry of hypoglycemia, worry of 
vascular complications) mediates the relationships between self-management and disease-
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related complications (i.e., episodes of severe hypoglycemia, the number of vascular 
complications) and avoidance behaviour, a similar set of hierarchical multiple regressions were 
conducted (as outlined above).  
A schematic of the worry of hypoglycemia mediation model is presented in Figure 9.  
Insert Figure 9 about here 
 The results of these analysis showed that a recent history of severe hypoglycemia was 
not a significant predictor of hypoglycemia avoidance behaviour (ß = .04, p < .63). However, 
severe hypoglycemia was positively associated with worry (ß = .27, p < .001), which in turn, 
was positively associated with hypoglycemia avoidance behaviour (ß = .38, p < .001). 
Although there is no evidence of mediation, these findings suggest a particular sequence of 
events that may contribute to both worry and and avoidance behaviour. Further examination of 
bivariate correlations showed that severe hypoglycemia was unrelated to hypoglycemia 
compensatory behaviours (r = .10, p < .21), and subtle avoidance behaviours (r = .07, p < .38). 
A summary of this mediation model is presenced in Table 13.  
Insert Table 13 about here 
 
A schematic of the worry of vascular complications mediation model is presented in 
Figure 10.  
Insert Figure 10 about here 
 
The results of these analyses showed that the number of vascular complications was not a 
significant predictor of hyperglycemia avoidance behaviour (ß = .12, p < .19). However, the 
number of vascular complications was positively associated with worry (ß = .26, p < .001); 
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with more complications being associated with greater worry. Since the independent effects 
between vascular complications and avoidance behaviour, and between worry and 
hyperglycemia avoidance behaviour, were not significant, there is no evidence of mediation. 
Further examination of bivariate correlations showed that vascular complications was 
significantly associated with complication vigilance/risk behaviour avoidance (r = .22, p < 
.01), but was unrelated to hyperglycemia compensatory/reassurance behaviour (r = .00, p < 
.99). A summary of this mediation model is presenced in Table 14.  
Insert Table 14 about here 
  
3.9.2 Diabetes-Related Worry, Alternative Worry Behaviours, and Outcomes 
As previously shown, the behaviour subscales of both the HFS and FOCQ tap a 
heterogeneous sample of worry behaviour. The results of the PCA described above showed 
that the HFS behaviour items measure hypoglycemia avoidance behaviours, hypoglycemia 
compensatory behaviours, and hypoglycemia subtle avoidance behaviours. Furthermore, it was 
also shown that the FOCQ behaviour items similarly measure complication vigilance/risk 
behaviour avoidance, hyperglycemia avoidance behaviour with diet and exercise, and 
hyperglycemia compensatory/reassurance behaviours. Since the primary analyses outlined 
above focused on avoidance behaviour as the primary mediating variable between diabetes-
related worry and both glycemic control and quality of life outcomes, the relationships between 
the diabetes-related worry, alternative worry behaviours (e.g., subtle avoidance behaviours, 
complication vigilance/risk behaviour avoidance, compensatory/reassurance behaviours) and 
outcomes will now be considered. First, Pearson correlations were calculated to examine the 
bivariate relationships among the variables. The worry and behaviour constructs that were 
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significantly associated with the outcomes (A1C, HRQoL) were further examined in a similar 
series of mediation models.  
The relationships between the diabetes-related worry, alternative worry behaviours, and 
A1C, are presented in Table 5. 
Insert table 5 about here. 
Examination of these correlations showed that none of these additional diabetes-related worry 
behaviours are significantly associated with A1C. Consequently, no further analyses were 
performed using A1C as a criterion variable.  
The relationships between diabetes-related worry, alternative worry behaviours, and 
HRQoL (perceived impact, self-management satisfaction) are presented in Table 15.  
Insert table 15 about here. 
 
Examination of these correlations showed that hyperglycemia compensatory/reassurance 
behaviour was significantly associated with perceived impact (r = .26, p < .01). Furthermore, 
hypoglycemia subtle avoidance behaviour was significantly associated with self-management 
satisfaction (r = .22, p < .01). While these latter associations are statistically significant, 
caution must be exercised in their interpretation given the magnatude of their relationships.   
 For similar reasons outlined in the primary analyses, I then sought to determine whether 
these alternative worry behaviours mediate the relationships between the diabetes-related 
worry (i.e., worry of hypoglycemia, worry of vascular complications) and HRQoL (perceived 
impact; self-management satisfaction). Subsequent analyses were considered if the 
hypothesized predictor, mediator, and criterion were each related at the bivariate level. Based 





 The purpose of this present study was to examine the impact of diabetes-related worry 
and avoidance behaviours on glycemic control and HRQoL in adults with T1DM. First, PCA 
was used to examine the structure of diabetes-related worry behaviour in this population. 
Through primary analyses, we examined that extent to which diabetes-related avoidance 
behaviours (e.g., hypoglycemia avoidance, hyperglycemia avoidance) mediate the relationships 
between diabetes-related worry and a variety of outcomes including glycemic control (i.e., 
A1C), and HRQoL (i.e., perceived impact, self-management satisfaction). Through exploratory 
analyses, I then examined the extent to which diabetes-related worry mediates the relationships 
between self-management and disease-related complications and diabetes-related avoidance 
behaviours. In this next section, these results will be summarized and integrated with the 
available literature. A discussion of the strengths and limitations of the present study will 
follow, and directions for future research will be offered.   
4.1 Diabetes-Related Worry Behaviours 
 Over the past few decades, researchers have asserted that worry of hypoglycemia 
adversely impacts blood glucose management (Cox et al., 1987; Wild et al., 2007); at least for 
certain subgroups of individuals with T1DM (Irvine et al., 1992). Although the experience of 
severe hypoglycemia may sensitize individuals to worry, and worry may motivate a variety of 
avoidance behaviours (Irvine, Cox, & Gonder-Frederick, 1992; Gonder-Frederick et al., 2006), 
researchers have not directly tested this mediation hypothesis. Rather, researchers and 
clinicians appear to have accepted this to be fact in the absence of supporting evidence. 
Contributing to this confusion, the mechanism(s) responsible for worsening glycemic control 
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have not been clearly delineated. Although researchers hypothesized that hypoglycemia 
avoidance behaviour is the likely culprit, the measure used to assess this construct taps more 
than overt avoidance behaviour. Recently, other researchers have turned their attention to 
worry of vascular complications as another diabetes-related worry construct that has the 
potential to influence diabetes self-management and outcomes (e.g., Taylor et al., 2005). Since 
the instrument used to measure this construct does not assess worry-driven behaviour, a worry 
of vascular complication behaviour subscale was generated for use in this current study. PCA 
was used to examine the component structure of these two behaviour dimensions, and the 
results of these analyses were incorporated into a series of mediation models.  
 The results of the first PCA revealed that the worry of hypoglycemia behaviour 
subscale is best be represented by a 3-factor solution, which accounts for 53% of the total 
variance. These items reflect facets of hypoglycemia avoidance behaviour (Factor 1), 
hypoglycemia compensatory behaviour (Factor 2), and hypoglycemia subtle avoidance 
behaviour (Factor 3). Although the authors of this 27-item measure conducted a factor analysis 
as part of the original validation study (Cox et al., 1987), their sample was limited to 35 
participants rendering their findings unreliable. To date, only one other PCA has been reported 
using an abbreviated version of the measure that was translated to Swedish (Anderbro, 
Amsberg, Wredling, Lins, Adamson, et al., 2008).  
The results of the second PCA revealed that the worry of vascular complications 
behaviour subscale is also best represented by a 3-factor solution, which accounts for 43% of 
the total variance. These items reflect facets of complication vigilance/risk behaviour 
avoidance (Factor 1), hyperglycemia avoidance behaviour with diet and exercise (Factor 2), 
hyperglycemia compensatory/reassurance behaviour (Factor 3). Since this behaviour subscale 
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was generated for use in this present study, this is the first examination of its component 
structure.  
 Although previous studies have explored the predictors and consequences of worry of 
hypoglycemia and worry of vascular complications (e.g., Gonder-Frederick et al., 2006; Irvine, 
Cox & Gonder-Frederick, 1992; Taylor et al., 2005), researchers have considered diabetes-
related worry behaviour to be homogeneous. While the practice of some behaviours may be 
motivated by worry, the impact of these behaviours may be divergent. Differentiating between 
types of worry behaviour has important implications for both research and clinical practice. For 
instance, it is likely that overt avoidance behaviour may have a more proximal impact on blood 
glucose, which over time, may exert cumulative effects on glycemic control. This is evidenced 
by a significant positive correlation between hypoglycemia avoidance behaviour and A1C in 
the adjusted model (see Figure 3). However, while subtle avoidance behaviours may be 
adaptive for diabetes management, they do not directly impact blood glucose. For instance, 
fast-acting sugar will only impact blood glucose if the sugar is ingested. Therefore, this subtle 
avoidance strategy may be associated with other psychosocial outcomes (e.g., self-efficacy), 
rather than blood glucose. Previous researchers have failed to differentiate among different 
types of worry behaviour, which may have contributed to the inconsistent associations with 
blood glucose parameters reported in previous studies (e.g., Cox et al., 1987; Irvine et al., 
1992).  
4.2 Relationships Between Diabetes-Related Worry and Worry Behaviours 
 The results of a series of bivariate correlations showed that worry of hypoglycemia was 
significantly associated with both avoidance and compensatory behaviour. However, worry of 
hypoglycemia was not significantly related to subtle avoidance behaviour. This suggests that 
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greater worry is associated with the more frequent practice of behaviours intended to avoid 
other than worry may motivate such behaviours. For instance, carrying fast acting sugar, such 
as glucagon, is promoted as an adaptive strategy for diabetes self-management. It is plausible 
that individuals can be motivated to minimize the likelihood of experiencing hypoglycemia for 
reasons other than worry (e.g., inconvenience as a result of severe hypoglycemia).  
In contrast, worry of vascular complications was positively associated with 
complication vigilance/risk behaviour avoidance. This suggests that worry is associated with 
the more frequent practice of behaviours intended to detect the signs and symptoms of vascular 
pathology (e.g., changes in visions, numbness or tingling in the extremities) and avoiding 
identified risk behaviours (e.g., alcohol consumption). However, the relationships between 
worry and both avoidance and compensatory behaviour were not statistically significant. 
Similarly, this lack of associations could mean that factors other than worry influence the 
practice of such behaviours.  
For instance, experiencing an acute episode of hyperglycemia results in symptoms that 
include excessive urination, excessive thirst, fatigue, itchy skin, and over time, weight loss. 
Individuals may be motivated to avoid hyperglycemic states to eliminate these symptoms 
because they may be sufficiently averse in their own right. Acute episodes of hyperglycemia 
may, or may not, trigger worry about vascular pathology because for some, the consequences 
may be too far down stream. In other words, the consequence of developing vascular 
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complications may be too distal from the experience of hyperglycemia for it to sufficiently 
motivate avoidance or compensatory behaviours to maintain or restore euglycemia.  
Interestingly, one of the strongest relationships was observed between worry of 
hypoglycemia and worry of vascular complications. This suggests that a general tendency to 
worry might underlie both of these constructs. In further support of this hypothesis, various 
vascular complication worry behaviours (e.g., complication vigilance/risk behaviour 
avoidance) were significantly associated with hypoglycemia worry behaviours (e.g., subtle 
avoidance behaviours, avoidance behaviour).    
4.3 Diabetes-Related Worry and Glycemic Control 
 To date, the research examining the relationships between diabetes-related worry and 
glycemic control has been mixed. Some researchers have reported significant relationships 
between worry of hypoglycemia and a variety of indices including blood glucose variability 
and history of hypoglycemia (e.g., Gonder-Frederick et al., 2006; Irvine, Cox & Gonder-
Frederick, 1992;). However, a relationship between worry and glycemic control (i.e., A1C) has 
not been shown (Cox et al., 1987; Irvine et al., 1992). Although researchers have hypothesized 
that worry motivates avoidance behaviour, which negatively influences glycemic control, no 
prior studies have tested this proposed mediation model. Furthermore, researchers have not 
considered a similar mediation model with the worry of vascular complications construct.   
 The results of a series of the analyses showed that hypoglycemia avoidance behaviour 
does not mediate the relationship between worry of hypoglycemia and A1C. However, in these 
analyses hypoglycemia avoidance behaviour is acting as a suppressor variable. For instance, 
the adjusted standardized ß-weight for the independent association between worry of 
hypoglycemia and A1C was not statistically significant (ß  = -.12, p < .20). However, when 
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hypoglycemia avoidance behaviour was included in the model, the direct effect of worry on 
A1C increased in magnitude and became statistically significant (ß  = -.20, p < .03). This 
suggests that hypoglycemia avoidance behavior suppressed irrelevant variance in A1C that 
strengthened its association with worry (Cohen, Cohen, West, & Aiken, 2003). Worry and 
avoidance behavior share variance with each other as evidenced by their significant 
relationship (ß  = .37, p < .001). Furthermore, the independent association between worry and 
A1C, and avoidance behavior and A1C are in the opposite direction. By failing to control for 
the variance in A1C accounted for by avoidance behavior, the relationship between worry and 
A1C was suppressed. The independent association between worry and A1C emerged only after 
controlling for avoidance behavior. In light of the inverse relationship between worry and A1C, 
it is possible that having a lower A1C increases the likelihood of experiencing hypoglycemia 
thereby increasing the degree to which individuals worry of hypoglycemia. The directionality 
of this association requires further examination using longitudinal research designs.  Overall 
however, based on the guidelines outlined by Barron and Kenny (1986), the current data do not 
support the originally hypothesized mediation hypothesis. The findings instead suggest that to 
reveal the nature of the relationship between worry of hypoglycemia and A1C, it is important 
to account for the extent to which individuals engage in hypoglycemia avoidance behavior.   
The results of our analyses also showed that hyperglycemia avoidance behaviour does 
not mediate the relationship between worry of vascular complications and A1C. In fact, the 
independent associations between worry and A1C, and avoidance behaviour and A1C, were 
not significant (p < .09). As described above, participants in this sample had reasonably well 
controlled blood glucose (mean A1C = 7.6). Although the results of exploratory analyses 
showed that the number of vascular complications accounted for 26% of the variance in worry, 
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the mean number of vascular complications among participants was .34 (SD = .67), and the 
modal number of complications that participants had developed was zero. Therefore, worry of 
vascular complications may not have been a particularly salient construct in this sample. 
However, if participants were more symptomatic of microvascular or macrovascular disease, 
we might expect the associations between worry, avoidance behaviour, and A1C to be more 
substantive.  
In a related line of research in our laboratory, a propensity to experience anxiety (i.e., 
anxious temperament) was found to be inversely associated with A1C among individuals 
newly diagnosed with T2DM (Hall, Coons & Vallis, 2008; Hall, Rodin, Vallis & Perkins, 
2009). This provides converging evidence that some manifestations of anxiety (i.e., worry of 
hypoglycemia, anxious temperament) are inversely associated with glycemic control among 
individuals with diabetes. Understanding the mechanisms responsible for these associations 
and outcomes will be important for future research.   
Interim Summary 
These findings suggest that the relationships between diabetes-related worry, avoidance 
behaviour, and glycemic control are complex. Although by definition, these data did not 
support the avoidance behaviour mediation hypotheses, they suggest that a series of related 
variables are associated with glycemic control. From the adjusted models, the experience of 
severe hypoglycemic episodes is associated with increased worry of hypoglycemia (ß = .27, p 
< .001), which is associated with hypoglycemia avoidance behaviour (ß = .37, p < .001). In 
turn, hypoglycemia avoidance behaviour is associated with worse glycemic control (ß = .22, p 
< .05). Worry of hypoglycemia is only associated with worse glycemic control (ß = -.20, p < 
.02) after controlling for hypoglycemia avoidance behavior, which is consistent with the 
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findings of previous research. Although the number of vascular complications was also 
associated with worry (ß = .26, p < .01), there was no independent association between worry 
of vascular complications and either avoidance behaviour (ß = .07, p < .44) or glycemic control 
(ß = .15, p < .10).  
4.4 Diabetes-Related Worry and Perceived Impact 
 Extending the mediation hypotheses considered above, it was hypothesized that 
diabetes-related avoidance behaviour would mediate the relationships between diabetes-related 
worry and HRQoL  (i.e., perceived impact, self-management satisfaction). The results of 
analyses involving worry of hypoglycemia and perceived impact were supported by these data. 
Specifically, worry of hypoglycemia was associated with of the perceived negative impact of 
having diabetes, and accounted for 52% of the variance. Furthermore, avoidance behaviour 
was also associated with perceived impact, and partially accounted for the relationship between 
worry and perceived impact.  
 Individual item analysis of the perceived impact subscale revealed that items enquire 
about the frequency of occurrence of events including having low blood sugar, being 
embarrassed about having to manage diabetes in public, feeling physically ill, having a bad 
not surprising that worry of hypoglycemia shares such an appreciable relationship with this 
construct, and that behaviours intended to avoid the threat of hypoglycemia helps to explain 
this association.   
 These data also showed that hyperglycemia avoidance behaviour does not mediate the 
relationship between worry of vascular complications and perceived impact. Rather, worry of 
vascular complications and hyperglycemia avoidance behaviour are independently associated 
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with the perceived negative impact of having diabetes. However, there was no independent 
association between worry of vascular complications and avoidance behaviour. Furthermore, 
the results of exploratory analyses showed that hyperglycemia compensatory/reassurance 
behaviour was similarly associated with these negative perceptions. 
It is logical that behaviours intended to avoid hyperglycemia that include avoiding 
eating out in restaurants, and avoiding eating carbohydrates and high calorie foods, may 
contribute to negative perceptions about having diabetes by the restrictions imposed on 
behaviors that are appreciated and valued (e.g., freedom in dietary choices). However, the 
association between worry of vascular complications and perceived impact is less intuitive.  
Drawing from cognitive behavioural theories, worry is associated with a bias to 
perceive information more negatively. In a recent meta-analytic review, Bar-Haim and 
colleagues (2007) found that across studies and populations, anxiety is associated with a threat-
related perceptual bias. This bias facilitates a process of hypervigilance toward threat in the 
environment (either external or internal), and may result in inaccurate conclusions being drawn 
about the nature and extent of potential threat. In this particular sample, the significant 
associations between worry and perceived impact could in part, be accounted for by an 
overactive threat-detection system. As individuals become increasingly worried of future 
vascular pathology, it is plausible that a negative perceptual bias becomes activated, which 
facilitates a selective focus on the negative aspects of living with diabetes.   
4.5 Diabetes-Related Worry and Self-Management Satisfaction 
These findings also showed that avoidance behaviour does not mediate the relationship 
between diabetes-related worry and self-management satisfaction. However, both worry of 
hypoglycemia and worry of vascular complications are associated with less satisfaction, 
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accounting for 17% and 42% of the variance, respectively. Interestingly, the difference in the 
magnitude of these effects is noteworthy. Severe hypoglycemia is an episodic and transient 
experience that, on average, occurs once or twice per year (Frier, 2008). In contrast, vascular 
complications represent irreversible medical conditions that contribute to blindness, renal 
failure, limb amputation, or other serious vascular events. Therefore, the gravity of these 
potential outcomes may help to explain why the independent association between worry of 
vascular complications and self-management satisfaction is considerably stronger than between 
worry of hypoglycemia and satisfaction.  
Furthermore, the results of analyses showed that both hyperglycemia avoidance 
behaviour and hypoglycemia subtle avoidance behaviour were positively associated with self-
management satisfaction. It is possible that the practice of such behaviours may serve an 
adaptive function that protects against dis- satisfaction with the outcome of diabetes self-
management practices. For instance, behaviours such as avoiding eating carbohydrates that 
would increase blood glucose, carrying fast acting sugar, or checking blood glucose more 
frequently in certain situations, may help to empower individuals to adaptively respond to 
blood glucose deviations if, and when, they occur. Over time, and with repeated practice, they 
may facilitate a greater sense of diabetes-related self-efficacy and overall satisfaction. This 
self-efficacy hypothesis in patients with diabetes has been reported by other researchers (e.g., 
Grey et al., 2001; Rubin, Peyrot & Saudek, 1993), and has been similarly demonstrated among 
patients with other chronic diseases (e.g., Rea et al., 2004).  
Interim Summary 
 The results of these analyses showed that diabetes-related worry is associated with the 
perceived impact of having diabetes and self-management satisfaction. Specifically, 
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hypoglycemia avoidance behaviour is an important mechanism that helps to explain the 
relationship between worry of hypoglycemia and perceived impact. Furthermore, worry of 
vascular complications and both hyperglycemia avoidance and compensatory/reassurance 
behaviours are similarly associated with the negative perceptions of the impact of having 
diabetes. However, hyperglycemia avoidance behaviour and hypoglycemia subtle avoidance 
behaviours are associated with greater satisfaction with self-management practices, suggesting 
that they may serve an adaptive function.  
4.6 Distinctions Between Diabetes-Related Worry and HRQoL 
 Given the magnitude of the observed associations between diabetes-related worry, 
perceived impact, and self-management satisfaction, are these dimensions tapping into the 
same underlying construct? When the DQOL was developed, the researchers of the Diabetes 
Control and Complications Trial sought to capture the nuances of diabetes that appear to have 
the greatest impact on the quality of life experiences. The original scale was comprised of 5 
subscales that include:  1) Impact of illness, 2) self-management satisfaction, 3) 
social/vocational worry, 4) diabetes-related worry, and 5) overall quality of life. The impact of 
illness and self-management satisfaction subscales were selected for use in this current study 
because they appeared to have the greatest potential to be impacted by diabetes-related worry 
and worry-driven behaviour. Although the DQOL contains a social and vocational worry 
subscale, items relate to worry about getting married, worry about whether or not individuals 
will have children, and worry about whether or not individuals will secure the job that they 
desire. For the diabetes-related worry subscale, items relate to worry about whether or not 
individuals will secure health insurance because of having diabetes, and worry about the 
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included that each assess worry about passing out, and worry about whether or not one will 
develop future complications. From the examination of these items, it seems that from early on, 
researchers appreciated that worry has the potential to impact the quality of life experiences for 
individuals with T1DM. However, the focus of the evaluation appears to have been on a 
heterogeneous sample of diabetes-related worries. Only two single items are vague 
approximations of the worry of hypoglycemia and worry of vascular complication constructs. 
However, these two particular items fail to capture the nature and extent of worry of both 
hypoglycemia and vascular complications, and do not begin to examine diabetes-related worry 
behaviours. Therefore, it appears that worry was conceptualized as an affective response that is 
central to the quality of life experiences of individuals with T1DM. However, worry of 
hypoglycemia, worry of vascular complications, and their associated worry behaviours, were 
peripheral to the conceptualization of HRQoL. 
4.7 Age, Diabetes-Related Worry Behaviours, and Perceived Impact 
Ancillary to the analyses described above, several interesting findings emerged 
involving age, avoidance behaviour, and perceived impact. First, age was inversely associated 
with hypoglycemia avoidance behaviours, and was positively associated with hyperglycemia 
avoidance behaviours. This suggests that the nature of avoidance behaviours may change as a 
function of increasing age. Specifically, as individuals age, they may be less likely to engage in 
hypoglycemia avoidance, and may be more likely to engage in hyperglycemia avoidance. 
Several potential explanations for these associations exist.   
as a function of the advancing disease process. Consequently, individuals may become 
increasingly aware of the importance of effective diabetes self-management to minimize the 
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risk of vascular complications and premature mortality. As such, the motivation to avoid 
hypoglycemia may be overridden by a more salient concern of vascular complications.  
hypoglycemia increases. In fact, individuals with T1DM experience one to two mild episodes 
per week, and one to two severe episodes per year (Frier, 2008). The nature and outcome of 
these glycemic deviations may influence the temporal dynamics of diabetes-related worry. 
Historically, if individuals have been successful at managing severe episodes of hypoglycemia, 
and averting dangerous or life-threatening outcomes (e.g., experiencing hypoglycemia while 
driving a vehicle), their worry may decrease as a function of their increased confidence in 
managing these events. However, if individuals have a history of experiencing dangerous or 
traumatic outcomes (e.g., seizures, hospitalizations) as a consequence of severe hypoglycemia, 
worry of hypoglycemia may remain salient.  
In two related lines of research, it has been reported that individuals with T1DM are 
twice 
compared to their non-diabetic spouses, and individuals with T2DM (Cox et al., 2001). The 
outcomes of these events likely influence a variety of both affective and behavioural responses. 
Others have shown that the perceived threat of death from an acute episode of hypoglycemia 
(e.g., following losses of consciousness or seizures) and worry about future episodes of 
hypoglycemia, are important contributing factors to the development of hypoglycemia-related 
posttraumatic stress symptoms (Myers et al., 2007). Under such conditions, individuals have 
been found to engage in significantly greater avoidant behaviour. This suggests that the 
outcomes of hypoglycemic episodes may be an important moderator of the association between 
age and avoidance behaviour. Although data in this current study failed to show a significant 
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relationship between severe hypoglycemia and avoidance behavior, hypoglycemia was positive 
associated with worry. Unfortunately, data in this present study were limited to the frequency 
of severe hypoglycemia. Consequently, examining the nature and outcomes of these 
experiences was not possible.   
Finally, age was also inversely associated with the perceived impact of having diabetes, 
they are less likely to perceive the impact of having diabetes in social and occupational 
domains to be negative. It is possible that over time, individuals with diabetes become 
instance, several of the items on the perceived impact subscale assess elements of social 
 often are you embarrassed by having to deal with your diabetes in 
the increased experience that comes with navigating these sensitive social situations over time, 
it is possible that the perception of negative impact diminishes. However, the positive effect of 
age on perceived impact may not be uniform across all individuals. For instance, there may be 
subgroups of individuals for whom the perceptions of social interference may remain high 
across the lifespan. In a recent study, Di Battista and colleagues (2009) reported that social 
anxiety was positively associated with the perceived impact of having diabetes; such that 
greater social anxiety was associated with greater perceived impact. Although these researchers 
surveyed a sample of adolescents with T1DM, this study suggests that social anxiety may be an 
important moderator of the association between diabetes-related worry and perceived impact, 





In addition to the independent variables included in the above analyses, age was 
significantly associated with several outcomes, and sheds some light on the temporal dynamics 
of diabetes-related worry behaviour and HRQoL. Age was significantly associated with 
avoidance behaviour; however, the function of the avoidance may change across time. As 
individuals age, they may be less likely to practice hypoglycemia avoidance behaviour, and 
more likely to engage in hyperglycemia avoidance behaviour. Although we are unable to 
discern the motivations for these differences, this may relate to the decreasing temporal 
advances, they are more likely to become symptomatic of vascular pathology. Therefore, 
individuals may become increasingly motivated to improve their glycemic control. 
Alternatively, as individuals age, the likelihood of experience other health problems increases. 
Therefore, the observed association between age and avoidance behaviour may be confounded 
by health status or the presence of other comorbid medical conditions. Although the cross 
sectional design of this current study prevents us from directly testing intertemporal choice 
theories, the associations between age and avoidance behaviour suggest that health-behaviour 
choices may be dynamic, and may be influenced by a variety of motivational and disease-
related factors. Furthermore, age was inversely associated with perceived impact, suggesting 
that over time, some individuals may adjust to the perceived life interference imposed by 
diabetes self-management practices.    
4.8 Strengths and Limitations 
 Data from this current study contribute to the psychosocial diabetes literature in a 
number of substantive ways. First, previous researchers have failed to differentiate between 
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diabetes-related worry behaviours. This was accomplished by subjecting the HFS behaviour 
subscale to a PCA. To date, researchers have not adequately assessed the component structure 
of the full English measure, let alone the behaviour dimension. This is also the first study to 
include a behaviour subscale to the FOCQ, which was similarly subjected to PCA.  
Second, researchers have assumed that diabetes-related worry and worry-driven 
behaviours uniformly impact a variety of important health outcomes. However, only a few 
studies have been published that directly assessed the impact of diabetes-related worry and 
worry-driven behaviour on glycemic control (Cox et al., 1987; Irvine et al., 1992; Taylor et al., 
2005). In a recent review of the worry of hypoglycemia literature, it was noted that researchers 
tend to selectively use the worry subscale only, and omit the behaviour subscale from analyses 
(Wild et al., 2007). These present findings suggest that assessing, and differentiating among 
different diabetes-related worry behaviours is indeed important in light of their unique 
associations with glycemic control, and HRQoL (perceived impact, self-management 
satisfaction).  
Third, it has been assumed that avoidance behaviour mediates the relationship between 
worry of hypoglycemia and glycemic control (Cox et al., 1987; Cox et al., 2001; Irvine et al., 
1992; Wild et al., 2007). Although intuitively this seems sensible, researchers have not directly 
tested this hypothesis, and the measure used to assess hypoglycemia avoidance captures more 
than simply avoidance behaviour. Furthermore, the worry of vascular complications behaviour 
subscale was constructed to capture similar heterogeneity. The results of our PCA confirm that 
diabetes-related worry behaviour is not homogenous. Rather, it is represented by a variety of 
behaviours that range from overt avoidance, compensatory, subtle avoidance, vigilance, and 
reassurance behaviours. Although each behaviour is intended to minimize the perils of both 
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hypoglycemia and vascular complications, the direct outcome of these behaviours is variable. 
These distinctions may appear to be semantic. However, they reflect important conceptual 
differences that influence how these constructs are both assessed and analyzed.  
Fourth, these data suggest that not all diabetes-related worry behaviours are the same, 
and some may be more adaptive than others. As anticipated by researchers, overt avoidance 
behaviour appears to have the greatest impact on A1C. However, hypoglycemia avoidance and 
compensatory behaviours are associated with the negative perceptions of having diabetes, and 
may be detrimental to self-management satisfaction. In contrast, hypoglycemia subtle 
avoidance, hyperglycemia avoidance, and complication vigilance/risk behaviour avoidance are 
associated with greater self-management satisfaction. These findings have importance 
implications for both research and clinical practice.  
Fifth, this is the first study to comprehensively examine the impact of temporally 
distributed diabetes-related worries and worry-driven behaviour on a variety of outcomes 
including glycemic control, and various HRQoL dimensions. Examining any one of these 
issues in isolation fails to account for the complexities inherent in the experience of living with 
T1DM.  
Although qualities of this study help to ensure its contribution to the literature, this 
present study is not without its shortcomings. First and foremost, the cross sectional nature of 
these data limit the conclusions that can be drawn for several reasons. We are unable to 
examine the temporal dynamics of diabetes-related worry and worry-driven behaviour across 
time and disease progression. Given the complex nature of the relationships between diabetes-
related worry, worry behaviour, and health outcomes, prospective examinations of these 
constructs will be paramount. Furthermore, we are unable to infer causality from these 
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observed associations. For instance, we found that worry of hypoglycemia and worry of 
vascular complications was associated with a variety of avoidance (overt and subtle), 
compensatory/reassurance, and vigilance/risk behaviour avoidance. However, it is plausible 
that diabetes-related worry behaviour creates a feedback loop through which the practice of 
worry behaviour maintains worry across time. In the anxiety disorders literature, this has been 
a well-documented phenomenon (for reviews, see Clark, 1999). To examine this possibility, 
studies employing longitudinal mediation models are needed (MacKinnon & Fairchild, 2009).  
Second, A1C was used as the primary outcome measure of glycemia. Although A1C is 
es a mean 
index of blood glucose. Consequently, it does not provide information on blood glucose 
variability. Irvine and colleagues (1992) have argued that individuals who are most susceptible 
to worry of hypoglycemia are individuals who experience a low mean blood glucose level, 
with a high degree of variability. This variability may contribute to a sense of unpredictability, 
and perhaps increases the likelihood of developing acute and significant glycemic deviations. 
Data on blood glucose variability would provide additional insight into the nature of the 
relationships between diabetes-related worry, worry behaviour, and health outcomes.  
medical records, rather than completing a separate blood draw for A1C analysis. Consequently, 
A1C values were not available for 23 participants. Factors that contributed to these missing 
appointments, and participants being treated for their diabetes outside of our three participating 
recruitment sites. Specifically, 11 participants were followed by community-based physicians 
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th information. Consequently, 
we were unable to collect these data.    
Finally, the participants sampled in this current study had reasonably well controlled 
blood glucose. Therefore, this restricted the range in A1C values. Since the vast majority of 
participants in our sample were Caucasian, and the majority of which were free from vascular 
pathology, these findings may not be representative of all individuals living with T1DM. 
Rather, these results may only be applicable to Caucasian individuals with moderately well 
controlled blood glucose, who are relatively free from significant vascular complications. 
4.9 Directions for Future Research 
 The results of this current study yield information that improves our understanding of 
the relationships between diabetes-related worry, worry-driven behaviour, and a variety of 
important health outcomes. However, future research is needed to address some important 
outstanding questions related to the nature and outcome of diabetes-related worry. While not 
exhaustive, the following section outlines some priorities for researchers.   
 First, all of the available research to date on diabetes-related worry has been cross-
sectional. Therefore, we are unable to evaluate the temporal dynamics of diabetes-related 
worry and worry-driven behaviour. Understanding how these affective and behavioural 
experiences change across time and disease progression will be important to determine their 
cumulative impact on diabetes self-management practices and outcomes. This can be 
accomplished by using prospective research designs.  
 Second, A1C was used as our primary outcome of glycemia. However, this measure 
fails to capture variability in blood glucose. Since diabetes-related worry is likely to influence 
s self-management practices at a momentary level, 
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examining worry, health behaviours, and glycemia using ecological momentary assessment 
(EMA) would be advisable. Technology such as continuous glucose monitoring systems, and 
Smartphone applications will enable researchers to examine these constructs in more 
sophisticated ways that increase the likelihood of deconstructing this complex biopsychosocial 
phenomena.  
 Third, the results of this current study only generalize to Caucasian individuals who 
have moderately well controlled diabetes. Therefore, researchers are encouraged to further 
explore the experience and outcome of diabetes-related worry with more ethnically diverse 
samples, and among individuals with more advanced, or less well controlled, T1DM.  
 Fourth, this is the second study that has examined the impact of worry of vascular 
complications on health outcomes in this population. To the best of my knowledge, this is also 
the first study to evaluate related worry-driven behaviour. Therefore, researchers would be 
advised to further explore these constructs, particularly among individuals who have developed 
more significant vascular pathology.  
 Fifth, this is the first study to conduct a PCA of the diabetes-related worry behaviour 
dimensions using an adequate sample size. These proposed component structures require 
confirmation using larger and more diverse samples of individuals with T1DM.   
 Finally, the results of our data suggest that the nature of diabetes-related avoidance 
behaviour changes as a function of increasing age. Furthermore, diabetes-related worry appears 
to influence the perceptions of the impact of having diabetes. To understand the conditions 
under which these relationships hold true, an examination of potential moderating variables is 
necessary. For instance, the outcome of severe hypoglycemic episodes that range from benign 
to life threatening will likely influence motivations to engage in hypoglycemia avoidance 
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behaviour. Furthermore, social anxiety has the potential to influence the perceived impact of 
having diabetes. These will be important variables to examine in future studies.  
4.10 Conclusion 
 Individuals with T1DM are faced with experiencing short-term complications 
associated with blood glucose variability, and long-term vascular-mediated complications 
including blindness, renal failure, persistent pain, heart attack, or stroke. The self-management 
decisions that individuals make have the potential to influence these outcomes in both positive 
and negative ways. It has been hypothesized that affective experiences, such as diabetes-related 
worry, might influence such choices. Specifically, researchers have argued that worry of 
hypoglycemia negatively impacts glycemic control through an avoidance behaviour 
mechanism. In this present study, I sought to test this hypothesis. Furthermore, this avoidance 
behaviour mediation hypothesis was extended to include the distally focused worry of vascular 
complications, and included other important HRQoL dimensions.  
 By and large, the avoidance behaviour mediation hypotheses were not supported by 
these data. However, several insights into the relationships between diabetes-related worry, 
worry-driven behaviour, and HRQoL outcomes were realized. Although researchers have 
argued that worry of hypoglycemia negatively impacts glycemic control, worry was not 
independently associated with A1C. In fact, hypoglycemia avoidance behaviour was the only 
factor that was independently associated with worse glycemic control. However, avoidance 
behavior suppressed irrelevant variance in A1C, which enhanced the magnitude of the 
relationship between worry and A1C. Worry of vascular complications and hyperglycemia 
avoidance behaviour were both unrelated to A1C in this particular sample.  
 
 75 
 These findings suggest that diabetes-related worry shares a complex relationship with 
glycemic control. The results of subsequent analyses also showed that these factors are 
differentially associated with HRQoL outcomes. Hypoglycemia avoidance behaviour is 
associated with the perceived negative impact of having diabetes, and helps to explain the 
relationship between worry of hypoglycemia and perceived impact. Worry of vascular 
complications and hyperglycemia avoidance behaviour with diet and exercise were similarly 
associated with perceived impact; however, hyperglycemia avoidance behaviour and a variety 
of other worry-driven behaviours (e.g., hypoglycemia subtle avoidance, complication 
vigilance/risk behaviour avoidance) are associated with greater satisfaction with self-
management practices and outcomes.  
Ancillary to the primary analyses, these results suggest that the nature of avoidance 
the practice of hypoglycemia avoidance behaviour is associated with being younger, and 
hyperglycemia avoidance behaviour was associated with being older. Although the specific 
mechanism(s) responsible for these associations cannot be elucidated from these data, a likely 
explanation involves the dynamics of the perceived temporal distance to the development of 
diabetes complications. As individuals age and diabetes advances, they may become less 
focused on the potential for experiencing hypoglycemia, and become more concerned with the 
possibility of developing significant vascular disease.  
 Considered together, these data suggest that the relationships between diabetes-related 
worry, worry-driven behaviour, and biopsychosocial outcomes are complex. Hypoglycemia 
avoidance behaviour is detrimental to blood glucose control, and diabetes-related worry and 
proactive avoidance behaviors are negatively associated with HRQoL. Clinically, this suggests 
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that diabetes-related worry and worry-driven behaviours are important constructs to assess in 
relation to both metabolic and psychosocial outcomes. Future research capitalizing on 
prospective designs is needed, and momentary assessment of psychological, behavioural, and 
metabolic constructs may be fruitful. The product of EMA will help to deconstruct the health 
decision-making process of individuals with T1DM. In turn, this will assist both researchers 
and clinicians in supporting individuals with T1DM to minimize the likelihood of significant 
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Figure 3 - Hypoglycemia Avoidance Behaviour Mediating the Relationship Between Worry of 


























Note: WoH = Worry of Hypoglycemia; HoAB = Hypoglycemia Avoidance Behaviour; * p < .05; ** P < .01, ***p 
< .001; Multiple regression models are adjusted for age, education, and mean household income. Coefficients are 
































Figure 4 - Hyperglycemia Avoidance Behaviour Mediating the Relationship Between Worry of 


























Note: WVC = Worry of Vascular Complications; HAB = Hyperglycemia Avoidance Behaviour with Diet and 
Exercise; * p < .05; ** p < .01; *** p < .001; Multiple regression models are adjusted for age, education, and 


































Figure 5 - Hypoglycemia Avoidance Behaviour Mediating the Relationship Between Worry of 


























Note: WoH = Worry of Hypoglycemia; HoAB = Hypoglycemia Avoidance Behaviour; PI = Perceived Impact; * p 
< .05; ** p < .01; ***p < .001; Multiple regression models are adjusted for age, education, mean household 
income, 12-month Frequency of Severe Hypoglycemia, Presence of Vascular Complications. Coefficients are 
standardized Beta weights. 
 






























Figure 6 - Hyperglycemia Avoidance Behaviour Mediating the Relationship Between Worry of 


























Note: WVC = Worry of Vascular Complications; HAB = Hyperglycemia Avoidance Behaviour with Diet and 
Exercise; PI = Perceived Impact; * p < .05; ** p < .01; ***p < .001; Multiple regression models are adjusted for 
age, education, mean household income, 12-month Frequency of Severe Hypoglycemia, Presence of Vascular 

































Figure 7 - Hypoglycemia Avoidance Behaviour Mediating the Relationship Between Worry of 

























Note: WoH = Worry of Hypoglycemia; HoAB = Hypoglycemia Avoidance Behaviour; SMS = Self Management 
Satisfaction; * p < .05; ** p < .01; ***p < .001; Multiple regression models are adjusted for age, education, mean 
household income, 12-month Frequency of Severe Hypoglycemia, Presence of Vascular Complications. 
Coefficients are standardized Beta weights. 
































Figure 8 - Hyperglycemia Avoidance Behaviour Mediating the Relationship Between Worry of 





























Note: WVC = Worry of Vascular Complications; HAB = Hyperglycemia Avoidance Behaviour with Diet and 
Exercise; SMS = Self-Management Satisfaction; * p < .05; ** p < .01; *** p < .001; Multiple regression models 
are adjusted for age, education, mean household income, 12-month Frequency of Severe Hypoglycemia, Presence 
































Figure 9 Worry of Hypoglycemia Mediating the Relationship Between Severe Hypoglycemia 



























Note: Severe Hypoglycemia = 12-month Frequency of Severe Hypoglycemia; WoH = Worry of Hypoglycemia; 
HoAB = Hypoglycemia Avoidance Behaviour; * p < .05; ** p < .01; ***p < .001; Multiple regression models are 

































Figure 10 - Worry of Vascular Complications Mediating the Relationship Between Presence of 



























Note: Microvascular Complications = Self-Reported Presence of Microvascular Complications; WVC = Worry of 
Vascular Complications; HAB = Hyperglycemia Avoidance Behaviour with Diet and Exercise; * p < .05; ** p < 
.01; *** p < .001; Multiple regression models are adjusted for age, education, and mean household income. 


















































































Table 1  Demographic Characteristics of Sample 
 
 M SD / % 
























6.5  % 
Education High School (some or completed) 
College/University (some) 
College/University (completed) 







































Table 2  Diabetes-Related Medical Characteristics 
 
 M SD / n 




























Coronary Artery Disease 
Cerebral Vascular Disease 






























Table 3  Shapiro-Wilk Tests of Normality 
 
Variable Shapiro-Wilk Statistic p 
WoH .93 .00 
HoAB .95 .00 
HoCB .98 .04 
HSAB .93 .00 
WVC .97 .02 
HAB .95 .00 
HC/RB .94 .00 
CV/RBA .98 .04 
Impact .94 .00 
Satisfaction .99 .63 
A1C .95 .00 
Hypoglycemic Episodes .81 .00 
Complications .57 .00 
 
Note:  WoH = Worry of Hypoglycemia; HoAB = Hypoglycemia Avoidance Behavior; HoCB = Hypoglycemia 
Compensatory Behavior; HSAB = Hypoglycemia Subtle Avoidance Behavior; WVC = Worry of Vascular 
Complications; HAB = Hyperglycemia Avoidance Behaviour with Diet and Exercise; HC/RB = Hyperglycemia 
Compensatory/Reassurance Behavior; CV/RBA = Complication Vigilance/Risk Behaviour Avoidance; Impact = 
Perceived Impact; Satisfaction = Self-Management Satisfaction; Hypoglycemic Episodes = 12-month Frequency 



























Table 4  HFS Behaviour 3-Factor Solution and Communalities 
 
Item F1 F2 F3 h2 
(4) I keep my sugar higher when I will be alone 
for a while. 
.840* .060 -.099 .719 
(7) I keep my blood sugar higher when I plan to 









(3) If test urine, I spill a little sugar to be on the 
safe side. If I test blood glucose, I run a little high 









(1) I eat large snacks at bedtime 
 
.436* .131 -.381 .352 
(5) I eat something as soon as I feel the first sign 
of low blood sugar 
-.216 .648* .037 .467 
(9) I avoid a lot of exercise when I think my 
sugar is low 
.026 .627* .408 .560 
(6) I reduce my insulin when I think my sugar is 
too low 
.272 .619* -.093 .466 
(2) I avoid being alone when my sugar is likely to 
be low 
.332 .519* -.115 .393 
(8) I carry fast-acting sugar with me -.018 -.153 .787* .643 
(10) I check my sugar often when I plan to be in a 
long meeting or go out to a party 
.125 .311 .701* .604 
 
Note:  *Salient factor loading (> .40); F1 = Hypoglycemia Avoidance Behaviours; F2 = Hypoglycemia 



























Table 5  FOCQ Behaviour 3-Factor Solution and Communalities 
 
Item F1 F2 F3 h2 
(21) I check the feeling/sensation in my hands 
and feet 
.778* .206 .014 .648 
(28) I check my feet for blisters, sores, or redness .757* .170 -.160 .627 
(23) I check for changes in my eye sight .712* .107 .193 .555 
(22) I check my blood pressure .605* -.152 .219 .437 
(26) I avoid drinking alcohol that would increase 
my blood sugar 
.460* .197 -.130 .267 
(27) I avoid eating carbohydrates to prevent high 
blood sugars 
-.084 .738* .110 .564 
(16) I avoid eating high calorie foods to prevent 
high blood sugars 
.245 .691* -.018 .537 
(25) I avoid eating out in restaurants to ensure 
that food is diabetic-friendly 
.105 .564* .007 .329 
(17) I exercise when I think that my blood sugar 
is too high 
.228 .519* .001 .321 
(24) I skip a meal if my blood sugar is too high -.094 .331 .700* .608 
(18) I take more insulin than usual if my blood 
sugar is too high 
.091 -.086 .535* .302 
(20) I ask to meet with my diabetes doctor more 
frequently than I need to 
.138 -.178 .437* .242 
(19) I purposely keep my blood sugar lower when 
I am around people that could assist me 
-.106 .188 .411* .215 
 
Note:  *Salient factor loading (> .40); F1 = Complication Vigilance/Risk Behaviour Avoidance; F2 = 


















Table 6  Correlations Between Diabetes-Related Worry and Worry Behaviours 
 


























































































































































Table 7 Hypoglycemia Avoidance Behaviour Mediating the Relationship Between Worry of 
Hypoglycemia and A1C 
 
  Variable ß p F R2 Significance 
of 2 
Model 1 
 DV = 
logA1C 
       
 Step 1    1.95 .05 .13 
  Sex .18 .05    
  Age -.13 .14    
  Income .04 .63    
 Step 2    1.90 .02 .12 
  logWoH -.12 .19    
Model 2 
 DV = 
logHoAB 
       
 Step 1    .91 .02 .44 
  Sex .05 .57    
  Age -.13 .13    
  Income -.02 .82    
 Step 2    6.20 .13 .000 
  logWoH .37 .00    
Model 3 
 DV = 
logA1C 
       
 Step 1    1.95 .05 .13 
  Sex .18 .05    
  Age -.13 .14    
  Income .04 .63    
 Step 2    2.62 .05 .03 
  logHoAB .22 .04    
  logWoH -.20 .02    
 













Table 8 Hyperglycemia Avoidance Behaviour Mediating the Relationship Between Worry of 
Vascular Complications and A1C 
 
  Variable ß p F R2 Significance 
of 2 
Model 1 
 DV = 
logA1C 
       
 Step 1    1.98 .05 .12 
  Sex .18 .05    
  Age -.13 .14    
  Income .04 .60    
 Step 2    2.15 .02 .11 
  logWVC .14 .11    
Model 2 
 DV = 
logHAB 
       
 Step 1    5.15 .10 .003 
  Sex -.07 .36    
  Age .29 .001    
  Income .08 .31    
 Step 2    4.01 .004 .43 
  logWVC .07 .43    
Model 3 
 DV = 
logA1C 
       
 Step 1    1.98 .05 .12 
  Sex .18 .05    
  Age -.13 .14    
  Income .04 .60    
 Step 2    2.33 .04 .07 
  logHAB -.16 .09    
  logWVC .15 .09    
 
Note:  WVC = log Worry of Vascular Complications; HAB = log Hyperglycemia Avoidance Behaviour with Diet 













Table 9 Hypoglycemia Avoidance Behaviour Mediating the Relationship Between Worry of 
Hypoglycemia and Perceived Impact 
 
  Variable ß p F R2 Significance 
of 2 
Model 1 
 DV = 
logPI 
       
 Step 1    .84 .02 .48 
  Sex .05 .60    
  Age -.13 .13    
  Income .02 .82    
 Step 2    1.57 .04 .08 
  SqrtComplications .12 .20    
  SqrtHypoglycemia .15 .09    
 Step 3    8.95 .23 .000 
  logWoH .52 .00    
Model 2 
 DV = 
logHoAB 
       
 Step 1    .91 .02 .44 
  Sex .05 .60    
  Age -.13 .13    
  Income -.02 .82    
 Step 2    6.20 .13 .000 
  logWoH .37 .00    
Model 3 
 DV = 
logPI 
       
 Step 1    .84 .02 .48 
  Sex .05 .60    
  Age -.13 .13    
  Income .02 .82    
 Step 2    1.57 .04 .08 
  SqrtComplications .12 .20    
  SqrtHypoglycemia .15 .09    
 Step 3    9.09 .27 .000 
  logWoH .44 .00    
  logHoAB .21 .01    
 
Note:  WoH = log Worry of Hypoglycemia; HoAB = log Hypoglycemia Avoidance Behaviour; PI = log Perceived 
Impact; Complications = Sqrt Number of Vascular Complications; Hypoglycemia = Sqrt 12-month Frequency of 






Table 10 Hyperglycemia Avoidance Behaviour Mediating the Relationship Between Worry of 
Vascular Complications and Perceived Impact 
 
  Variable ß p F R2 Significance 
of 2 
Model 1 
 DV = 
logPI 
       
 Step 1    .85 .02 .47 
  Sex .05 .60    
  Age -.13 .13    
  Income .02 .82    
 Step 2    1.58 .04 .08 
  SqrtComplications .12 .20    
  SqrtHypoglycemia .15 .09    
 Step 3    7.01 .18 .000 
  logWVC .46 .00    
        
Model 2 
 DV = 
logHAB 
Step 1    5.15 .10 .10 
  Sex -.07 .36    
  Age .29 .001    
  Income .08 .31    
 Step 2    4.01 .10 .43 
  logWVC .07 .43    
Model 3 
 DV = 
logPI 
       
 Step 1    .85 .02 .47 
  Sex .05 .60    
  Age -.13 .13    
  Income .02 .82    
 Step 2    1.58 .04 .08 
  SqrtComplications .12 .20    
  SqrtHypoglycemia .15 .09    
 Step 3    6.97 .21 .000 
  logWVC .45 .00    
  logHAB .18 .02    
 
Note:  WVC = log Worry of Vascular Complications; HAB = log Hyperglycemia Avoidance Behaviour with Diet 
and Exercise; PI = log Perceived Impact; Complications = Sqrt Number of Vascular Complications; Hypoglycemia 






Table 11 Hypoglycemia Avoidance Behaviour Mediating the Relationship Between Worry of 
Hypoglycemia and Self-Management Satisfaction 
 
  Variable ß p  F R2 Significance 
of 2 
Model 1 
 DV = 
zSMS 
       
 Step 1    1.70 .04 .17 
  Sex -.06 .48    
  Age .12 .17    
  Income .12 .15    
 Step 2    2.58 .05 .03 
  SqrtComplications -.25 .01    
  SqrtHypoglycemia -.01 .92    
 Step 3    2.85 .03 .05 
  logWoH -.17 .05    
Model 2 
 DV = 
logHoAB 
       
 Step 1    .91 .02 .44 
  Sex .05 .60    
  Age -.13 .13    
  Income -.02 .82    
 Step 2    6.20 .13 .000 
  logWoH .37 .00    
Model 3 
 DV = 
zSMS 
       
 Step 1    1.70 .04 .17 
  Sex -.06 .48    
  Age .12 .17    
  Income .12 .15    
 Step 2    2.58 .05 .03 
  SqrtComplications -.25 .01    
  SqrtHypoglycemia -.01 .92    
 Step 3    2.65 .04 .07 
  logWoH  -.14 .15    
  logHoAB -.11 .24    
 
Note:  WoH = log Worry of Hypoglycemia; HoAB = log Hypoglycemia Avoidance Behaviour; SMS = z-Self-
Management Satisfaction; Complications = Sqrt Number of Vascular Complications; Hypoglycemia = Sqrt 12-






Table 12 Hyperglycemia Avoidance Behaviour Mediating the Relationship Between Worry of 
Vascular Complications and Self-Management Satisfaction 
 
  Variable ß p  F R2 Significance 
of 2 
Model 1 
 DV = 
zSMS 
       
 Step 1    1.72 .17 .04 
  Sex -.06 .48    
  Age .12 .17    
  Income .12 .15    
 Step 2    2.60 .09 .03 
  SqrtComplications -.25 .01    
  SqrtHypoglycemia -.01 .92    
 Step 3    7.26 .25 .000 
  logWVC -.42 .00    
Model 2 
 DV = 
logHAB 
       
 Step 1    5.15 .10 .002 
  Sex -.07 .36    
  Age .29 .001    
  Income .08 .31    
 Step 2    4.01 .004 .43 
  logWVC .07 .43    
Model 3 
 DV = 
zSMS 
       
 Step 1    1.72 .17 .04 
  Sex -.06 .48    
  Age .12 .17    
  Income .12 .15    
 Step 2    2.60 .09 .03 
  SqrtComplications -.25 .01    
  SqrtHypoglycemia -.01 .92    
 Step 3    6.97 .27 .000 
  logWVC -.43 .00    
  logHAB .16 .04    
 
Note:  WVC = log Worry of Vascular Complications; HAB = log Hyperglycemia Avoidance Behaviour with Diet 
and Exercise; SMS = z-Self-Management Satisfaction; Complications = Sqrt Number of Vascular Complications; 






Table 13 Worry of Hypoglycemia Mediating the Relationship Between Severe Hypoglycemia 
and Hypoglycemia Avoidance Behaviour  
 
  Variable ß p F R2 Significance 
of 2 
Model 1 
 DV = 
logHoAB 
       
 Step 1    .96 .02 .42 
  Sex .06 .51    
  Age -.13 .13    
  Income -.02 .78    
 Step 2    .77 .002 .63 
  SqrtHypoglycemia .04 .63    
Model 2 
 DV = 
logWoH 
       
 Step 1    1.83 .04 .14 
  Sex .14 .09    
  Age .09 .29    
  Income .07 .40    
 Step 2    4.11 .07 .001 
  SqrtHypoglycemia .27 .00    
Model 3 
 DV = 
logHoAB 
       
 Step 1    .96 .02 .42 
  Sex .06 .51    
  Age -.13 .13    
  Income -.02 .78    
 Step 2    4.71 .13 .000 
  SqrtHypoglycemia -.06 .48    
  logWoH .38 .00    
 
Note:  WoH = log Worry of Hypoglycemia; HoAB = log Hypoglycemia Avoidance Behaviour; Hypoglycemia = 













Table 14 Worry of Vascular Complications Mediating the Relationship between Vascular 
Complications and Hyperglycemia Avoidance Behaviour  
 
  Variable ß p F R2 Significance 
of 2 
Model 1 
 DV = 
logHAB 
       
 Step 1    5.06 .10 .002 
  Sex -.06 .43    
  Age .28 .00    
  Income .09 .28    
 Step 2    4.25 .01 .19 
  SqrtComplications .12 .19    
Model 2 
 DV = 
logWVC 
       
 Step 1    2.73 .06 .46 
  Sex .22 .01    
  Age .05 .54    
  Income -.09 .30    
 Step 2    4.24 .11 .005 
  SqrtComplications .26 .00    
Model 3 
 DV = 
logHAB 
       
 Step 1    5.06 .10 .002 
  Sex -.06 .43    
  Age .28 .00    
  Income .09 .28    
 Step 2    3.43 .01 .37 
  SqrtComplications .11 .25    
  logWVC .04 .61    
 
Note:  WVC = log Worry of Vascular Complications; HAB = log Hyperglycemia Avoidance Behaviour with Diet 





Table 15 - Correlations between Worry Behaviour and Health Related Quality of Life Constructs 
 



































































































































Note:  * p < .05, ** p < .01; Impact = log Perceived Impact; Satisfaction = z-Self-Management Satisfaction. All remaining variables were logarithmically 
transformed. 


















































Hypoglycemia F ear Survey 
This survey is intended to find out more about how low blood sugar makes people feel and behave. Please answer 
the following questions as frankly as possible. Below is a list of things people with diabetes sometimes do in order 
to avoid low blood sugar. Read each item carefully. Circle one of the numbers to the right that best describes what 
you do during your daily routine to avoid low blood sugar. 
 










1. Eat large snacks at 
bedtime 
1 2 3 4 5 
2. Avoid being alone when 












3. If test urine, spill a little 
sugar to be on the safe 
side. If test blood glucose, 
run a little high to be on 











4. Keep my sugar higher 












5. Eat something as soon as 












6. Reduce my medication 
(insulin/pills) when I 











7. Keep my blood sugar 
higher when I plan to be 

























9. Avoid a lot of exercise 












10. Check my sugar often 
when I plan to be in a 





















Below is a list of concerns people with diabetes sometimes have. Please read each item carefully (please do not skip 
any). Circle one of the numbers to the right that best describes how often you worry about each item because of low 
blood sugar.  
 










11. Not recognizing/realizing 
I am having a reaction 
1 2 3 4 5 
12. Not having food, fruit, or 
juice with me 
1 2 3 4 5 
13. Feeling dizzy or passing 
out in public 
1 2 3 4 5 
14. Having a reaction while 
asleep 
1 2 3 4 5 
15. Embarrassing myself or 
my friends/family in a 
social situation 
1 2 3 4 5 
16. Having a reaction while 
alone 
1 2 3 4 5 
17. Appearing stupid or 
drunk 
1 2 3 4 5 
18. Losing control 
 
1 2 3 4 5 
19. No one being around to 
help me during a reaction 
1 2 3 4 5 
20. Having a reaction while 
driving 
1 2 3 4 5 
21. Making a mistake or 
having an accident at 
work 
1 2 3 4 5 
22. Getting a bad evaluation 
at work because of 
something that happens 
when my sugar is low 
1 2 3 4 5 
23. Having seizures or 
convulsions 
1 2 3 4 5 
24. Difficulty thinking clearly 
when responsible for 
others (children, elderly, 
etc.) 
1 2 3 4 5 
25. Developing long-term 
complications from 
frequent low blood sugar 
1 2 3 4 5 
26. Feeling lightheaded or 
faint 
1 2 3 4 5 
27. Having an insulin 
reaction 
1 2 3 4 5 




Fear of Complications Questionnaire - Worry 
This questionnaire is designed to help us understand how you feel about your diabetes and how it affects you, 
particularly in the long-term. Please answer the following questions as honestly as possible.  
 
1. I feel afraid of long-term 








Not at all 
2. I worry about losing my eyesight 
because of Diabetes 
All the 
time 
Frequently Occasionally Never 
3. I worry that having Diabetes 




Frequently Occasionally Never 
4. I am afraid I will need a kidney 
transplant one day 
Very Moderately A little Not at all 
5. I am afraid of developing long-term 
complications as a result of 
frequent high blood sugars 
All the 
time 
Frequently Occasionally Never 
6. I am afraid that I may need kidney 
dialysis one day 
Never Occasionally Frequently All the 
time 
7. I am afraid that I will develop 
kidney problems on day 
All the 
time 
Frequently Occasionally Never 
8. How often do you think about long-
term complications of Diabetes? 
Never Occasionally Frequently All the 
time 
9. I worry that I might be at a higher 
risk for having a stroke 
All the 
time 
Frequently Occasionally Never 




Occasionally Frequently All the 
time 
11. I worry that the Diabetes Specialist 




Occasionally Frequently All the 
time 
12. Do you worry about future 




Occasionally Frequently All the 
time 
13. I am scared that Diabetes could 
affect my feet 
Very Moderately A little Not at all 
14. I am scared of having a heart attack 
in the future 
Not at 
all 
A little Moderately Very 
15. I worry about developing problems 
with circulation 












Fear of Complications Questionnaire - Behaviour 
These questions are designed to help understand the things that you do to avoid or prevent long-term complications 
of diabetes from high blood sugars. Please answer the following questions as honestly as possible.  
 
1. I avoid eating high calorie foods to 
prevent high blood sugars. 
Always Frequently Occasionally Never 
2. I exercise when I think that my 
blood sugar is too high. 
Always Frequently Occasionally Never 
3. I take more insulin than usual if my 
blood sugar is too high. 
Never Occasionally Frequently Always 
4. I purposely keep my blood sugar 
lower when I am around people that 









5. I ask to meet with my diabetes 
doctor more frequently than I need 
to.  
Always Frequently Occasionally Never 
6. I check the feeling/sensation in my 
hands and feet.  
Never Occasionally Frequently Always 
7. I check my blood pressure.  
 
Always Frequently Occasionally Never 
8. I check for changes in my eyesight.  
 
Never Occasionally Frequently Always 
9. I skip a meal if my blood sugar is 
too high. 
Always Frequently Occasionally Never 
10. I avoid eating out (e.g., restaurants) 
to ensure that food is diabetic-
friendly.  
Always Frequently Occasionally Never 
11. I avoid drinking alcohol that would 
increase my blood sugar. 
Never Occasionally Frequently Always 
12. I avoid eating carbohydrates to 
prevent high blood sugars. 
Always Frequently Occasionally Never 
13. I check my feet for blisters, sores, 
or redness. 
















Diabetes Quality of L ife 
The following questionnaire asks about how your diabetes has affected many different areas of your life. Please 




















1. How satisfied are you with the 
amount of time it takes to 











2. How satisfied are you with the 












3. How satisfied are you with the 

























5. How satisfied are you with the 












6. How satisfied are you with the 
burden your diabetes is placing 











7. How satisfied are you with your 

























9. How satisfied are you with your 

























11. How satisfied are you with your 












12. How satisfied are you with the 












13. How satisfied are you with the 







































































or A lways 
Worried 
5 
16. How often do you feel pain 












17. How often are you embarrassed 
by having to deal with your 





































20. How often does your diabetes 

























22. How often do you find your 
diabetes limiting your social 
























24. How often do you feel restricted 












25. How often does your diabetes 












26. How often does your diabetes 
keep you from driving a car or 











27. How often does your diabetes 
















28. How often do you miss work, 
school, or household duties 











29. How often do you find yourself 












30. How often do you find that your 












31. How often do you tell others 












32. How often are you teased 












33. How often do you feel that 
because of your diabetes you go 












34. How often do you find that you 












35. How often do you hide from 
others the fact that you are 
having an insulin reaction? 
 
1 
 
2 
 
3 
 
4 
 
5 
 
 
 
 
 
 
 
 
 
 
